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1. ABSTRACT 
 
 The functions of many organs depend on the 
generation of an epithelium. The transition from a set of 
loosely connected nonpolarized cells to organized sheets of 
closely associated polarized epithelial cells requires the 
assembly of specialized cell junctions. In vertebrates, three 
major types of junctions are responsible for epithelial 
integrity: adherens junctions, tight junctions, and 
desmosomes. p120 catenin (p120ctn) is an Armadillo 
family member and a component of the cadherin–catenin 
complex in the adherens junction. It fulfils pleiotropic 
functions according to its subcellular localization: 
modulating the turnover rate of membrane-bound 
cadherins, regulating the activation of small RhoGTPases 
in the cytoplasm, and modulating nuclear transcription. 
Over the last two decades, knowledge of p120ctn obtained  
 
 
 
 
from in vitro experiments has been confirmed and extended 
by using different animal models. It has become clear that 
p120ctn is essential for normal development and 
homeostasis, at least in frog and mammals. p120ctn is a Src 
substrate that can be phosphorylated at different tyrosine, 
serine and threonine residues and can dock various kinases 
and phosphatases. Thereby, p120ctn regulates the 
phosphorylation status and the junctional stability of the 
cadherin–catenin complex. Multiple p120ctn isoforms are 
generated by alternative splicing, which allows the 
translation to be initiated from four start codons and 
enables the inclusion of four alternatively used exons. We 
will discuss the effects of different p120ctn isoforms on 
cadherin turnover and intracellular signaling, in particular 
RhoGTPase activity and phosphorylation events.
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2. INTRODUCTION 
 
Multicellular organisms rely on dynamic cell–cell 
adhesion systems to sustain the development and 
homeostasis of embryos and tissues. Several types of 
junctions have been identified in epithelial cells: tight 
junctions, desmosomes, gap junctions and adherens 
junctions. Tight junctions (reviewed in 1, 2) connect 
adjacent cells and create a barrier that is almost 
impermeable to fluids. In this way, tight junctions regulate 
movement of ions and solutes between cells. Tight 
junctions consist of the transmembrane proteins occludin 
and claudin, and the cytoplasmic scaffolding proteins ZO-
1, -2, and -3, which link tight junctions to the actin 
cytoskeleton. Desmosomes (reviewed in 3, 4) are 
intercellular junctions that anchor membrane-associated 
plaque proteins to intermediate filaments. This anchoring 
provides mechanical strength. Desmosomes consist of 
desmosomal cadherins (desmoglein and desmocollin) and 
cytoplasmic plaque proteins (such as the Armadillo 
proteins plakoglobin and plakophilins), which bind to 
desmosomal cadherins, as well as to desmoplakin, which 
binds to intermediate filaments. Gap junctions (reviewed in 
5) are aggregated channels that connect adjacent cells and 
permit the exchange of ions and small molecules. Gap 
junctions chemically couple cells and allow easy 
intercellular communication. Gap junction channels are 
composed of two end-to-end paired connexons, each of 
which consists of hexamers of connexins, which are the 
principle structural components of gap junctions. Adherens 
junctions (Figure 1A) consist of cadherin–catenin 
complexes in which single-span transmembrane cadherin 
molecules mediate calcium-dependent homophilic 
interactions via their extracellular domains. Mammalian 
genomes contain over 100 genes belonging to the cadherin 
superfamily (6). E-cadherin is the prototype of the classic 
cadherin family. This family is characterized by the 
presence of five tandem extracellular cadherin repeats 
(EC1-5) that function in calcium-dependent homophilic 
adhesion (7). The cytoplasmic domain of E-cadherin serves 
as a scaffold for catenins, which link cadherin-mediated 
cell adhesion to the actin cytoskeleton, either directly or 
indirectly (8). Two conserved catenin-binding domains are 
present, a membrane proximal domain (juxtamembrane 
domain, JMD) for binding p120catenin (p120ctn) and a 
beta-catenin binding domain (CBD). This review covers the 
structure and versatile functions of p120ctn. 
 
p120ctn binds to various cadherins and regulates 
their stablility on the cell surface. We will discuss the 
mechanism of p120ctn-regulated cadherin turnover in 
Section 4. In addition, p120ctn plays a role in other 
subcellular compartments (Figure 1): it modulates 
RhoGTPase activity in the cytoplasm (Section 5) and 
regulates nuclear transcription (Section 6). The Armadillo 
protein p120ctn was first identified as a Src substrate (9). 
Other kinases and phosphatases can either interact with 
p120ctn or change its phosphorylation status (see Section 
7). Depletion of p120ctn in vivo has shown that p120ctn is 
indispensable for normal vertebrate development, at least in 
frog and mammals (Section 8). On the other hand, 
deregulation of p120ctn is common in human cancer, and 
p120ctn influences several processes that are involved in 
tumor formation and progression (Section 9). During the 
previous decade, it has become clear that p120ctn is not 
translated as a single protein but as different isoforms (see 
Section 3). Although the existence of p120ctn isoforms has 
been known for a long time, their regulation and 
significance in p120ctn biology remains largely unresolved. 
We will review current knowledge of p120ctn, with special 
focus on the various isoforms, how they are expressed, and 
how they influence the many functions of p120ctn. 
 
3. p120ctn ISOFORMS AND ALTERNATIVE 
SPLICING  
 
The human p120ctn gene (CTNND1) is located 
on chromosome 11q11. Following its cloning in 1998, it 
was found that inter- and intra-exonic splicing events 
generate multiple p120ctn mRNA variants encoding 
different isoforms (10). Up to forty-eight putative p120ctn 
isoforms might be generated by using four different 
translation initiation sites (M1-4) combined with four 
alternatively spliced internal exons (A to D; Figure 2) (10, 
11). Each p120ctn isoform consists of a large central 
Armadillo repeat domain flanked by an N-terminal and a 
C-terminal region (Figure 2). This central domain has nine 
Armadillo repeats, each of which consists of three helices 
(12, 13). The central domain is not affected much by 
alternative splicing. Only the six amino acid residues (AA) 
encoded by the alternatively spliced exon C, also called 
exon 11, are located in an insert loop between Armadillo 
repeats ARM5 and ARM6, but this probably does not cause 
conformational changes in the overall structure of the 
Armadillo repeat domain (12, 13). p120ctn 1ABC (968 
AA) is the longest isoform, contains all the alternatively 
spliced internal exons, and has the longest N-terminal 
domain because it is translated from the first start codon 
(Figure 2). p120ctn isoform 3 has a shortened N-terminal 
domain because it lacks 100 AA containing a coiled-coil 
domain, whereas p120ctn isoform 4 lacks almost the entire 
N-terminal domain, including the phosphorylation domain 
(PD), which contains most of the phosphorylation sites.  
 
In general, p120ctn is ubiquitously expressed 
during development and in adult organisms, except in 
several non-adherent hematopoetic cell lines and in loosely 
organized SW48 colon carcinoma cells, which exhibit only 
weak p120ctn expression (14, 15). p120ctn isoform 1 (long 
isoform) and p120ctn isoform 3 (short isoform) display 
tissue-specific and cell-specific expression patterns. 
Isoform 1 is predominantly expressed in highly motile 
cells, such as fibroblasts (e.g. NIH3T3 cells) and 
macrophages (14, 16, 17). In normal tissues, p120ctn 
isoform 1 is predominantly expressed in the central and 
peripheral nervous systems, heart, spleen, testis, ovary and 
endothelial cells (11, 18, 19). In contrast, isoform 3 is 
abundant in epithelial cell lines (14, 16, 17) and in 
epithelial structures of the skin and the gastro-intestinal 
lining, which have a rapid turnover, as well as in kidney, 
liver, pancreas, mammary gland and prostate (10, 11, 18, 
19). These cells and tissues show bias for expression of 
certain p120ctn isoforms, but most cells and tissues express 
both long and short isoforms. Since long p120ctn isoforms 
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Figure 1. p120ctn performs different functions in different subcellular compartments. (A) Adherens junctions (AJ) in epithelial 
cells consist of transmembrane E-cadherins that bind to beta-catenin and p120ctn via their cytoplasmic tails. Beta-catenin binds 
to alphaE-catenin, which can link to the actin cytoskeleton via an adaptor (e.g. Eplin) or as a dimeric complex not coupled to the 
cadherins. p120ctn binds to the juxtamembrane domain of cadherins and prevents their endocytosis. Internalized cadherin 
molecules can be recycled or targeted for degradation. A p120ctn–PLEKHA7–Nezha chain forms a bridge between the cadherin–
catenin complex and the minus ends of microtubuli. Cytoplasmic p120ctn can regulate the activity of RhoGTPase family 
members. (B) p120ctn is also involved in the Wnt signaling pathway. Right: In the absence of Wnt ligand, the beta-catenin 
destruction complex promotes the degradation of beta-catenin. This complex is composed of adenomatous polyposis coli (APC), 
glycogen synthase kinase-3beta (GSK3β), casein kinase-1alpha (CK1α), beta-transducin repeat-containing protein (β-TrCP) and 
axin. Also p120ctn is not available for the Wnt pathway because it binds to E-cadherin at the AJ or because it is degraded. When 
beta-catenin and p120ctn in signaling pools are reduced, TCF/LEF and Kaiso function as transcriptional repressors in the 
nucleus. Left: In the presence of Wnt ligand, both beta-catenin and p120ctn become available for the Wnt pathway. Beta-catenin 
enters the nucleus to relieve the repression by TCF–LEF. Simultaneously, cytoplasmic (and nuclear) p120-catenin becomes 
available to associate with Kaiso, resulting in derepression of Kaiso target genes, some of which are shared with beta-
catenin/TCF–LEF. p120ctn also binds Frodo, which interacts with Dishevelled (Dsh), a Wnt pathway component. LRP, low-
density lipoprotein receptor-related protein; TBE, TCF binding elements; KCS, Kaiso consensus (binding) sequence. 
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Figure 2. Structure of p120ctn isoforms. The structural features depicted include interaction domains, subcellular localization 
signals, phosphorylation sites, and alternative splice forms. The p120ctn domains for binding different interaction partners are 
shown at the top. p120ctn contains two conventional nuclear localization signals (NLS) and a nuclear export sequence (NES). 
Armadillo repeats (ARM) 3, 5 and 8 have also been implicated in nuclear trafficking. Due to alternative splicing, four translation 
start sites (1 to 4) can be used. Alternatively used exons A, B and C, encoding 21, 29 and 6 AA, respectively, can be included, 
whereas exon D (encoding 24 AA) is rarely excluded. p120ctn isoform 1ABC is the longest isoform, employs the first start 
codon, and contains all alternatively spliced exons. CC, coiled coil domain; CTR, carboxy-terminal (non-Armadillo) region; 
NTR, amino-terminal (non-Armadillo) region; PD, phosphorylation domain, comprising many Ser, Thr and Tyr residues that are 
phosphorylated under particular conditions; RBD, RhoA-binding domain. 
are expressed in endothelial cells, which are present in all 
organs, tissue preparations from any organ might contain 
long isoforms derived from endothelial cells. Interestingly, 
a switch from short to long p120ctn isoforms is seen during 
epithelial-to-mesenchymal transition (EMT), which can be 
induced by expression of c-Fos (20), Snail (21), SIP1/ZEB2 
(22, 23), E47 (23), Slug (23), Twist (24) or Zeppo1 (25). 
 
Two epithelial splicing regulatory proteins 
(ESRP1 and ESRP2) favor the expression of epithelial 
isoforms of various proteins, including the short ‘epithelial’ 
p120ctn isoform (24). Reduction of ESRP1 and ESRP2 
levels by RNAi-mediated knockdown or by Twist-induced 
EMT resulted in a switch from short to long p120ctn 
isoforms. Reciprocally, expression of ‘epithelial’ p120ctn 
in mesenchymal cells could be induced by ectopic 
expression of ESRP1, which causes a switch toward the 
epithelial splicing pathway (24). Some expression changes 
characteristic of EMT (e.g. up-regulation of vimentin 
protein) were also observed upon silencing of ESRPs, 
whereas others (e.g. downregulation of E-cadherin protein) 
were not (26). Nonetheless, immunofluorescence analysis 
of E-cadherin showed that ESRP knockdown led to loss of 
E-cadherin from cell–cell contacts. These observations 
suggest that ESRP down-regulation contributes to loss of 
epithelial properties, although ‘full’ EMT obviously 
requires additional changes in gene expression. 
 
The diversity of p120ctn transcripts in man and 
mouse is increased by alternative splicing of internal exons. 
Exon A encodes a 21-AA sequence (Figure 2) that is 
ubiquitously expressed in various human cell lines and 
tissues (10). Exon B encodes a putative nuclear export 
signal (NES) with a characteristic leucine motif that 
counteracts the nuclear localization of p120ctn isoform 3A 
(27). Exon C encodes six AA that interrupt the second 
nuclear localization signal (NLS2) of p120ctn, which 
coincides with the second RhoA-binding domain (RBD2) 
(Figure 2). Expression of exon C indeed blocks 
translocation to the nucleus and at the same time inhibits 
dendritic-like branching (Pieters et al., in preparation) (see 
also Section 5). Exon C is strongly expressed in brain (10) 
(Pieters et al., in preparation). A rare deletion of a fourth 
alternatively spliced internal exon, exon D, was reported in 
fetal and adult brain tissue (11). In conclusion, the 
alternative usage of p120ctn exons is tissue-specific, and it 
might regulate the subcellular localization of p120ctn 
isoforms and direct their functionality. 
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4. p120ctn REGULATES CADHERIN TRAFFICKING 
AND STABILITY 
 
4.1. p120ctn and cadherin biogenesis  
Adhesive structures have to be highly dynamic so 
that cells can maintain homeostasis by adapting to internal 
and external signals. Consequently, cadherin–catenin 
complexes are highly dynamic and are constantly 
assembled and disassembled (Figure 1A). Cadherin 
trafficking involves cadherin synthesis in the Golgi, 
transport to the cell surface, stabilization at the cell surface 
or internalization, and recycling or proteasomal or 
lysosomal degradation (28, 29). After its synthesis, E-
cadherin binds to beta-catenin, and together they are 
transported from the Golgi complex to the plasma 
membrane (30, 31). Unlike beta-catenin, p120ctn does not 
interact with E-cadherin during its biogenesis (32). Indeed, 
p120ctn-uncoupled E-cadherin is still properly targeted to 
the plasma membrane (33). On the other hand, cadherin-
binding is essential for localizing p120ctn at the membrane: 
introducing exogenous E-cadherin in E-cadherin-negative 
cells relocalized p120ctn from the cytoplasm to the 
membrane (33). In contrast, p120ctn has been reported to 
associate with N-cadherin early during its biogenesis (34). 
Both N-cadherin and p120ctn move along microtubule 
tracks towards cell–cell contacts (35, 36). p120ctn isoform 
1 colocalizes and interacts with microtubules and the motor 
protein kinesin, which transports cargo towards the plus 
ends of microtubules (towards the plasma membrane) (36-
38). The N-terminal domain of p120ctn binds to the heavy 
chain of kinesin, but an N-terminal deletion mutant and the 
naturally occuring p120ctn isoform 4 do not (36, 37, 39). 
p120ctn isoform 1, which contains the entire N-terminal 
domain, binds to kinesin with a higher affinity than p120ctn 
isoform 3, which lacks 100 AA of the N-terminus (37). 
p120ctn, and in particular its isoform 1, might therefore 
play a role in delivering N-cadherin to the plasma 
membrane. Indeed, disassembly of the N-cadherin–
p120ctn–kinesin complex delayed the delivery of N-
cadherin to cell–cell contacts (36).  
 
4.2. p120ctn stabilizes cell surface cadherin 
Mature adherens junctions are formed after the 
synthesis and transport of cadherins and catenins to the 
membrane (Figure 1A). p120ctn plays an important role in 
the binding and stabilization of membrane-localized 
cadherins. The juxtamembrane domain (JMD) of classical 
cadherin interacts with the Armadillo repeat domain of 
p120ctn (17, 40), and Armadillo repeats 1 to 5 of p120ctn 
are essential for this interaction (13, 15). Both isoform 1 
(long) and isoform 3 (short) of p120ctn can bind E-
cadherin (16). The crystal structure of p120 isoform 4A in 
complex with the core region of the E-cadherin JMD 
(mouse E-cadherin AA 758–775) has been determined (13). 
The Armadillo repeat domain of p120ctn contains modular 
binding pockets that are complementary to the electrostatic 
and hydrophobic properties of the JMD core. Single-
residue mutations within the JMD-binding site of p120 
abolished the interaction of mutant p120ctn with E- and N-
cadherins in vitro (13) and interfered with cell–cell 
adhesion (33). These findings indicate that p120ctn serves 
as a gatekeeper of cadherin turnover (41). We will discuss 
the effect of Ser/Thr phosphorylation of p120ctn on the 
stablility of cadherins in junctions in Section 7. 
 
The first clue that p120ctn is critical for cadherin 
function emerged from analysis of SW48 colon carcinoma 
cells bearing mutations in the p120ctn gene (15). Due to 
p120ctn insufficiency, these poorly differentiated cells 
failed to form compact colonies and displayed less E-
cadherin protein but not reduced E-cadherin mRNA (15). 
Epithelial morphology and cadherin levels could be rescued 
by expressing p120ctn isoform 1, 3 or 4, or by using a 
RhoA-uncoupled variant of p120ctn isoform 1 (delta662-
628), but not by using an E-cadherin-uncoupled p120ctn 
mutant. Pulse chase experiments revealed that p120ctn 
expression increased the E-cadherin half-life (15). Stable 
knockdown of p120ctn in mammalian cells resulted in a 
drastic and dose-dependent decrease in cadherins, such as 
E-, N-, P-, VE-cadherin and cadherin-11 (42-45). Loss of 
p120ctn also resulted in decreased expression of beta- and 
alpha-E-catenin due to decreased cadherin levels (42, 43). 
Human cells depleted of p120ctn became dispersed, but 
introduction of a murine p120ctn cDNA rescued both 
morphology and cadherin levels (42). 
 
Morpolino-mediated depletion of p120ctn in 
Xenopus and its genetic depletion in mouse confirm that 
p120ctn can stabilize cadherins in vivo. Knockdown of 
p120ctn in Xenopus embryos reduces the levels of classical 
cadherins (46, 47). Moreover, gastrulation defects seen 
upon p120ctn depletion in Xenopus could be rescued by 
ectopic expression of C-cadherin (47, 48). Tissue-specific 
p120ctn depletion in mice decreases the levels of E-
cadherin (49-52), N-cadherin (51, 53, 54), P-cadherin (49) 
and VE-cadherin (54). In conclusion, p120ctn regulates 
cadherin turnover at the cell membrane both in vitro and in 
vivo. 
 
4.3. p120ctn prevents endocytosis of cadherins 
p120ctn controls the expression levels of 
membrane-localized cadherins partly by preventing their 
endocytosis. Cell surface cadherins can be internalized via 
different pathways (reviewed in (29)), including clathrin-
dependent endocytosis, caveolae-mediated endocytosis, 
lipid-raft-mediated endocytosis, and micropinocytosis. The 
decision to enter a certain endocytotic pathway is highly 
cell-specific but it also depends on the microenvironment. 
p120ctn blocks clathrin-mediated endocytosis of VE-
cadherin, and this block depends on the binding of p120ctn 
to the JMD of VE-cadherin (55). Other studies showed 
increased E-cadherin endocytosis in cells expressing a 
p120ctn-uncoupled E-cadherin mutant as well as in cells in 
which p120ctn was depleted by RNAi (56). It is not clear 
how p120ctn prevents endocytosis, but the following 
possibilities have been proposed. First, p120ctn competes 
with presenilin-1 and Hakai for binding to the JMD of 
classical cadherin. Presenilin-1 favors E-cadherin 
degradation by proteolytic cleavage of the cadherin 
cytoplasmic tail (57, 58). Hakai is an E3 ubiquitin ligase 
that binds to the phosphorylated tyrosine motifs in the JMD 
of E-cadherin (but does not bind other classical cadherins). 
This leads to ubiquitination and endocytosis of E-cadherin 
(Figure 1A) (59, 60). Second, a dileucine motif in the 
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cytoplasmic tail of E-cadherin (close to the JMD) is 
responsible for clathrin-mediated internalization of E-
cadherin (56). If the dileucine motif is mutated or if the 
cadherin tail is completely deleted, E-cadherin is not 
endocytosed (56, 61). p120ctn might regulate E-cadherin 
endocytosis by masking the dileucine motif to prevent its 
interaction with adaptor proteins, such as AP-2, which are 
required for clathrin-mediated endocytosis (62). In 
conclusion, it is conceivable that p120ctn acts as a “cap” 
that binds cadherin and prevents its endocytosis.  
 
4.4. p120ctn localization at microtubules 
 In many cell types, microtubules (MTs) are 
organized in a radial array with their minus ends anchored 
at the centrosome and their plus ends extending toward the 
cell periphery. On the other hand, terminally differentiated 
cells might contain both centrosomal and noncentrosomal 
MTs. In polarized epithelial cells, noncentrosomal MTs are 
arranged along the apicobasal axis of the cell with their 
minus ends oriented apically and their plus ends basally. In 
both arrangements of MTs, p120ctn has been found at the 
minus ends.  
 
 A recent study revealed that the N-terminal 
domain of p120ctn interacts with PLEKHA7 (pleckstrin 
homology domain-containing, family A member 7) (63). In 
the adherens junction of polarized epithelial cells, a 
p120ctn–PLEKHA7–Nezha chain forms a bridge between 
the cadherin–catenin complex and the minus ends of 
microtubules (Figure 1A). The integrity of the adherens 
junction is dependent on this macromolecular complex, 
possibly because this complex recruits KIFC3, a minus-end 
directed microtubular motor, towards the junctions (63). 
Depletion of PLEKHA7, Nezha or KIFC3 resulted in 
disorganization of the adherens junction. Hence, that study 
revealed a novel p120ctn-dependent mechanism for 
regulation of cell–cell contacts. 
 
 It should be noted that p120ctn (39, 64, 65), 
PLEKHA7 (63), and KIFC3 (63) can localize in the 
centrosomes, which indicates that they perform functions 
there. We found that Kaiso, a p120ctn interaction partner, 
localizes at the mitotic spindle and is a constituent of the 
pericentriolar material (66). Chartier et al. (64) showed that 
overexpression of p120ctn isoform 3A leads to its 
accumulation at the centrosomes of mitotic HT29 cells. 
Interestingly, it has been proposed that isoform 3A rather 
than isoform 1A directly interacts with Kaiso (67). These 
observations require further investigation to elucidate the 
place of p120ctn in the regulation of MT minus ends. 
 
5. p120ctn AND RHOGTPASES 
 
5.1. RhoGTPases and cadherin-based junctions 
The activities of the small GTPases RhoA, Cdc42 
and Rac1 play a central role in regulation of cytoskeletal 
dynamics, formation and maintenance of adherens 
junctions, and migration of cells (68). Furthermore, 
cadherin recycling is important both during the formation 
of new contacts and in the maintenance of stable junctions 
(69). RhoGTPases regulate many stages of vesicular 
trafficking, but they affect cadherin-based junctions in 
ways that vary with the cellular environment (69-72). 
RhoGTPases have been shown to be important for 
cadherin-based adhesion in vivo. Rho1, the Drosophila 
RhoA homolog, colocalizes with DE-cadherin in embryos, 
and both the cadherins and catenins are mislocalized in 
Rho1 mutants (73). In conclusion, an intricate relationship 
exists between RhoGTPases and the formation and 
maintenance of cadherin-based junctions. 
 
 
5.2. p120ctn and dendritic-like branching  
The first hint about the role of p120ctn in altering 
RhoGTPase activity came from p120ctn overexpression 
studies. Expressing large amounts of exogenous p120ctn 
saturated cadherin-binding sites, and the excess p120ctn 
translocated to the cytoplasm and caused a neuron-like 
cellular morphology similar to dendritic branching (74). 
This phenotype was likely due to p120ctn-mediated RhoA 
inhibition because the phenotype could be mimicked by 
adding a RhoA inhibitor (C3 exotransferase) and by 
expressing p190RhoGAP (70, 75). On the other hand, the 
dendritic-like branching could be blocked by coexpressing 
a constitutively active (CA) RhoA variant (75-77) and by 
mutating one of the RhoA-binding sites of p120ctn (75, 
78). Indeed, an N-terminal deletion that includes RBD1 
diminishes p120ctn-induced branching (78), but branching 
is completely blocked by deleting a second RhoA-binding 
domain (containing AA 622-628; Figure 2) (75). Is this 
branching phenotype RhoA-specific or are there other 
RhoGTPases involved? Activation of Rac1 and Cdc42 also 
influences p120ctn-mediated branching because branching 
was blocked by dominant negative forms of Rac1 and 
Cdc42 in two studies (76, 77). However, this was not seen 
in another study (75).  
 
5.3. p120ctn inhibits RhoA activity and activates both 
Rac1 and Cdc42 
Compelling evidence that p120ctn modulates 
RhoA activity comes from two kinds of observations: 
p120ctn overexpression results in RhoA inhibition, whereas 
its knockdown or genetic ablation in mice results in 
increased RhoA activity. First, expression of p120ctn 
isoform 1A inhibits RhoA activation in 293T and CHO 
cells (75, 76). A deletion mutant of p120ctn isoform 1A, 
named delta622-628 and lacking the RBD2, failed to 
inhibit RhoA activity and to induce dendritic-like 
branching (75). Also, cells transfected with p120ctn 
isoform 1A do not form actin stress fibers due to weak 
RhoA activity (75-77). In a complementary approach, 
stable knockdown of endogenous p120ctn in different cell 
lines resulted in RhoA activation (43, 45, 79-81) and 
strongly enhanced formation of actin stress fibers (43, 79). 
These p120ctn-depleted cell lines are also suitable for 
testing the effect of various p120ctn isoforms on RhoA 
activity. These isoforms originate from another species and 
are therefore unaffected by the shRNA used to knock down 
the original p120ctn. The p120-mediated RhoA inhibition 
can be rescued by introducing p120ctn isoform 1, but not 
p120ctn isoform 4, in p120ctn-depleted cell lines (45, 80). 
Finally, modulation of RhoA activity by p120ctn is also 
observed in vivo, as genetic ablation of p120ctn in mouse 
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skin and dorsal forebrain result in increased RhoA 
activation (49, 53). 
 
p120ctn expression also results in increased Rac1 
and Cdc42 activity (76, 77). In line with this, knockdown 
or knockout of p120ctn results in decreased Rac1 activity 
(45, 53, 80). Re-expression of both p120ctn isoforms 1 and 
4 in stable p120ctn-knockdown lines results in reactivation 
of Rac1 (80, 82). Remarkably, p120ctn isoform 4 can 
restore Rac1 activity while it fails to inhibit RhoA activity, 
indicating that a single p120ctn isoform can differentially 
regulate the activity of different RhoGTPases. Overall, 
p120ctn regulates RhoGTPase activity by inhibiting RhoA 
and activating Rac1 and Cdc42, which in turn alters 
cytoskeletal dynamics and increases cell migration (76). 
 
5.4. Interaction between p120ctn and RhoA  
Does p120ctn bind to RhoA or is it involved 
indirectly in regulating its activity? In Drosophila, p120ctn 
binds directly to Rho1, the RhoA homolog (73). 
Remarkably, also alpha-catenin binds to Rho1 in 
Drosophila, but alpha-catenin and p120ctn bind to distinct 
regions of the N-terminus of Rho1 (73). One RhoA binding 
domain (RBD1) has been identified in the N-terminus of 
mouse p120ctn (AA 102-234) (Figure 2) (83). Binding of 
this RBD1 domain to RhoA is regulated by tyrosine 
phosphorylation of RBD1 by Src family members. Fyn-
mediated phosphorylation of Tyr residue Y112 or 
introduction of a phosphomimetic Y112E mutation inhibits 
the interaction of p120ctn with RhoA and prevents 
p120ctn-mediated dendritic-like branching and RhoA 
inhibition. On the other hand, Fer- or Src-mediated 
phosphorylation of Y217 and Y228 increases the affinity 
between p120ctn and RhoA, which leads to inhibition of 
RhoA activity (83). RhoA activity was also inhibited by 
expressing a Y112F mutant of p120ctn that cannot be 
phosphoryated by Fyn (83). RBD1 on its own does not 
have RhoGDI activity, indicating that additional sequences 
in p120ctn are required for RhoA inhibition and for 
RhoGDI functionality (83). The second RhoA binding 
domain (RBD2, AA622–628) coincides with NLS2 of 
p120ctn (Figure 2). The delta622–628 mutation of p120ctn 
isoform 1 fails to reduce intrinsic or GEF-induced RhoA 
activation but does not elicit dendritic-like branching (75). 
Deleting either RBD1 (like in isoform 4) or RBD2 (like in 
mutant delta622–628 of isoform 1) does not prevent GDP-
RhoA from binding to p120ctn (80). However, deleting 
both RBDs of p120ctn, as in a delta622–628 mutant of 
isoform 4, completely abrogates the ability of p120ctn to 
bind GDP-RhoA in vitro (80).  
 
5.5. Mechanism of p120ctn-mediated RhoA inhibition 
The mechanism by which p120ctn inhibits RhoA 
is still unclear, but two mechanisms have been postulated: 
either p120ctn can bind to RhoA (see above) and act as a 
Rho guanine nucleotide dissociation inhibitor (GDI), or it 
can activate Rac1, which leads to RhoA inhibition 
mediated by p190RhoGTPase activating protein 
(p190RhoGAP) (Figure 3).  
 
In the first proposed mechanism, p120ctn binds 
to RhoA and prevents its activation by Rho guanine 
exchange factors (GEFs). p120ctn has been shown to 
specifically inhibit the intrinsic GDP/GTP exchange 
activity of RhoA, which resembles the mode of action of 
GDIs (75, 83). Also, in vitro translated and purified 
Drosophila p120ctn preferentially binds to GDP-bound 
Rho1 (73). In addition, p120ctn binds dominant-negative 
(DN) Rho1 but not constitutively active (CA) Rho1 (73). 
The p120ctn-binding region of Rho1 adopts different 
conformations depending on which nucleotide is bound, 
and this might explain the binding preference of p120ctn 
for GDP-bound Rho1 (73). Although p120ctn has no 
sequence similarity to GDI, it interacts with the same face 
of RhoA protein as GDI does (73, 84).  
 
The second proposed mechanism involves 
interplay between several RhoGTPases. Rac1 and Cdc42 
can inhibit RhoA activity in NIH3T3 cells (85). p120ctn 
can interact with Vav2, a Rho family GEF, which might 
account for the p120ctn-mediated activation of Rac1 and 
Cdc42 (76). Therefore, p120ctn-mediated Rac1 activation 
might indirectly inhibit RhoA through a pathway that 
involves LMW-PTP and p190RhoGAP (Figure 3) (79, 86, 
87). 
 
5.6. Effect of p120ctn on RhoGTPase activity is cell-type 
specific 
After the first reports on the dendritic-like 
branching induced by cytoplasmic p120ctn, it turned out 
that this effect varies with cell type, assay conditions, 
micro- and macro-environments, and types of cadherins 
expressed. Therefore, it is impossible to make general 
conclusions about dendritic-like branching and RhoGTPase 
activity, and it is necessary to keep an open mind to new 
and possibly unexpected results. For example, in one study 
the knockdown of p120ctn in DU145 prostate cancer cells 
did not affect the activities of RhoA and Rac1 (88). But in 
another study, cytoplasmatic p120ctn activated RhoA in 
primary cells derived from a mouse model of invasive 
lobular carcinoma, whereas knockdown of p120ctn in these 
cells resulted in RhoA inhibition (207). In contrast to the 
dogma stating that p120ctn isoform 1 inhibits RhoA 
activity and activates Rac1 and Cdc42 (see Section 5.3), in 
lung cancer cells p120ctn isoform 1 blocks Rac1 activity 
whereas isoform 3 activates RhoA and inhibits Cdc42 
activity (89). Knockdown of p120ctn in lung cancer cell 
lines results in inhibition of RhoA and activation of Rac1 
and Cdc42 (90).  
 
RhoGTPase signaling is altered by cadherin 
expression. p120ctn interacts with cadherins, and dendritic-
like branching can be blocked by co-expression of p120ctn 
with E- or C-cadherin (75, 76). Expression of C-cadherin 
constructs encoding the complete cytoplasmic domain or 
just the JMD can sequester overexpressed p120ctn to the 
cell membrane, but not if the construct encodes beta-
catenin binding domain CBD alone without the JMD (76). 
Similar findings were reported by use of soluble fragments 
of the E-cadherin cytoplasmic domain (75). On the other 
hand, E-cadherin binding is dispensable for p120ctn-
induced dendritic-like branching because E-cadherin-
uncoupled p120ctn mutants lacking either Armadillo repeat 
1 (ARM1) or Armadillo repeats 1-3 (ARM1-3) can still 
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Figure 3. p120ctn regulates the activities of RhoGTPases, which function as molecular switches that alternate between an active 
(GTP-bound) and an inactive (GDP-bound) state. Guanine exchange factors (GEFs) promote RhoGTPase activation, whereas 
GTPase activating proteins (GAPs) and Rho guanine dissociation inhibitor (GDI) contribute to RhoGTPase inactivation. p120ctn 
has been shown to activate Rac1 (and Cdc42) and to inhibit RhoA activity. Indeed, p120ctn interacts with the Rho family GEF 
Vav2, which can directly activate Rac1. On the other hand, p120ctn can inhibit RhoA either by its RhoGDI activity or by Rac1-
mediated activation of p190RhoGAP via the ‘Bar-Sagi’ pathway (depicted on a gray background). This ‘simple’ hypothesis has 
not been confirmed in all studies. ROS, reactive oxygen species; LMW-PTP, low molecular weight protein tyrosine 
phosphatases.  
 
elicit a branched morphology (45, 74). Endogenous 
p120ctn activates Rac1 in E-cadherin-negative MDA-MB-
231 cells, but this activation is lost upon stable expression 
of exogenous E-cadherin (82). In addition, p120ctn-
mediated Rac1 activation is not observed in MCF7 cells, 
which express endogenous E-cadherin (82). Like cadherins, 
microtubules can tether p120ctn away from the cytoplasmic 
pool and thereby prevent p120ctn-induced dendritic-like 
branching. Coexpression of the kinesin heavy chain 
reduced the branching elicited by p120ctn isoform 1 but not 
the branching elicited by isoform 3; this means that isoform 
1 has a higher affinity for kinesin (37).  
 
5.7. p120ctn isoforms and dendritic-like branching  
In an initial report by Reynolds et al. (17), 
p120ctn isoform 1A was shown to induce dendritic-like 
branching. A follow-up study revealed that p120ctn 
isoforms 2A and 3A, but not 4A, also elicit dendritic-
like branching. Remarkably, there seems to be a 
correlation between nuclear localization of p120ctn 
and its ability to elicit branching. p120ctn isoform 1 
can be imported into the nucleus and it induces 
dendritic-like branching, whereas isoform 4, which 
lacks the N-terminal domain and was never localized 
in the nucleus, did not induce branching (78). 
Because p120ctn isoform 4 lacks the phosphorylation 
domain, there might also be a link between 
phosphorylation and dendritic-like branching. In 
addition, both p120ctn isoforms 1AB and 3AB have 29 
additional AA encoded by the alternatively spliced exon B 
and containing a NES (Figure 2). p120ctn isoforms 1AB 
and 3AB can block branching and promote nuclear export 
(27, 78). Mutational analysis revealed a second NES in 
Armadillo repeat 7 [new repeat numbering based on (12, 
13)] (38). Full-length p120ctn contains two conventional 
nuclear localization sequences, NLS1 and NLS2 (Figure 2). 
Deleting NLS1 does not prevent branching (78). However, 
branching is abolished by mutation (91) or deletion (75) of 
NLS2. Interrupting NLS2 by expression of six AA encoded 
by the alternatively spliced exon C disrupts both dendritic-
like branching and nuclear translocation (Pieters et al., in 
preparation). NLS2 comprises AA 622–628, which 
coincide with the second RhoA binding domain, RBD2 
(Figure 2). Remarkably, nuclear import is not fully 
blocked by mutating the two conventional NLSs, and an 
additional role has been proposed for the Armadillo 
repeat domain in nucleocytoplasmic shuttling. Indeed, 
Armadillo repeats 3 and 5 of p120ctn turned out to be 
essential for nuclear import (38). Deleting them both by 
removing either repeats ARM3-5 or repeats ARM3-9 
blocks the neuron-like morphogenesis (74, 77). 
Interestingly, the p120ctndeltaARM3-5 construct still 
contains both RhoA-binding domains but nevertheless 
fails to induce branching (74, 77). Is nuclear import of 
p120ctn per se enough to induce branching? No, 
because forced nuclear translocation of p120ctn 
(following administration of Leptomycin B or coupling 
of an SV40 NLS) does not trigger dendritic-like 
branching (91). In conclusion, the p120ctn isoforms 
differ in their ability to elicit a branched morphology, 
and this is often correlated with their ability to 
translocate to the nucleus. 
6. p120ctn MODULATES SIGNALING IN SEVERAL 
CELL COMPARTMENTS 
 
6.1. p120ctn modulates signaling in the nucleus  
In adherens junctions, E-cadherin interacts with 
beta-catenin and p120ctn. Both Armadillo proteins, when 
released from junctions, travel to the nucleus, where they 
act as transcriptional regulators (Figure 1B). In canonical 
Wnt signaling, beta-catenin is generally considered the key 
transmitter of Wnt signals to the nucleus (92-94). However, 
p120ctn can also localize in the nucleus (27, 38, 78, 91, 
95). Nuclear trafficking of p120ctn depends on 
conventional NLS and NES signals (Figure 2) (27, 78, 91), 
as well as on the p120ctn Armadillo repeat domain (38) and 
on the microenvironment (96). p120ctn interacts with 
transcription factors Kaiso (67) and Glis2 (97). Kaiso also 
contains a functional NLS for its nuclear import (98). 
p120ctn might also associate with Kaiso in the cytoplasm, 
which would tether away Kaiso from the nucleus and 
thereby prevent it from acting in the nucleus (99). 
 
 
Kaiso is composed of an N-terminal poxvirus and 
zinc finger (POZ) domain and three carboxy-terminal zinc 
fingers. The POZ domain also enables Kaiso to 
homodimerize (67, 100), whereas its C-terminal zinc finger 
domain can bind to DNA. Kaiso has a dual specificity for 
DNA: it can bind to sequence-specific Kaiso consensus 
(binding) sites (KCS) and to methylated CpG-dinucleotides 
(101, 102). Remarkably, the Kaiso function involving 
binding to sequence-specific KCSs is dispensable in 
Xenopus laevis (103). However, the binding of Kaiso to 
methylated DNA is evolutionarily conserved (103) and 
allows histone-deacetylase-dependent transcriptional 
repression. This involves the recruitment of chromatin co-
repressor components, such as nuclear co-repressor 1 
(NCOR) (104), to the N-terminal POZ domain of Kaiso. 
On the other hand, the Armadillo repeat domain of p120ctn 
can bind to the C-terminal zinc finger domain of Kaiso and 
thereby inhibit Kaiso’s interaction with DNA (67). Kaiso 
acts as a transcriptional repressor. The binding of p120ctn 
to Kaiso blocks this repressor activity, which therefore 
results in activation of Kaiso target genes, such as Siamois, 
c-Fos, Myc, Ccnd1 (encodes Cyclin D1) (105), xWnt11 
(106), and Mmp7 (encodes Matrilysin) (107).  
 
There is significant overlap between the target 
genes of the p120ctn–Kaiso and beta-catenin–TCF 
signaling pathways, and cross-talk between these pathways 
has been reported. This synergism has been observed both 
in cell lines (107) and in Xenopus embryos (105). The 
promoter of the matrilysin gene contains two KCSs, and 
Kaiso can repress beta-catenin-induced activation of the 
Mmp7 gene. This Kaiso-mediated transcriptional repression 
of Mmp7 has been found to be reversed by p120ctn 
expression (107). Several other beta-catenin target genes 
contain KCSs, and in Xenopus embryos they can be either 
repressed by Kaiso or activated by either beta-catenin 
activity or Kaiso depletion (105). p120ctn relieves the 
Kaiso-mediated repression of beta-catenin target genes, 
whereas its ablation in Xenopus embryos increases their 
repression (105).  
Table 1. Overview of kinases and phosphatases, which bind cadherins and catenins and/or modify their phosphorylation status 
Protein kinases1 Phosphoprotein phosphatases1 
 Subtrates  Non-receptor 
 kinases 
Receptor  
tyrosine kinases Non-receptor phosphatases 
Receptor-associated 
phosphatases 
Cadherins 
E-cadherin v-Src (172) EGFR (189) PTP1B (190),  PP2A (S/T) (191) PTPmu (192) 
N-cadherin v-Src (193) FGFR-4 (194) PTP1B (195) PTPmu (192) 
VE-cadherin c-Src (196) VEGFR-2 (140, 196, 197) PTP1B (198) VE-PTP (199) 
R-cadherin       PTPmu (192) 
Catenins 
alpha-catenin ? ? ? ? 
beta-catenin 
Fer (119),  
Fyn (119),  
Yes (119),  
c-Src (119), 
v-Src (17, 146, 172) 
EGFR (189),  
TrkA (139),  
VEGFR-2 (140),  
c-Met (132) 
PTP1B (190, 195),  
SHP2 (200),  
PP2A (S/T) (191) 
DEP1 (143, 144),  
PTPkappa (201),  
PTP-LAR (202, 203),  
PTPlabda (204),  
PCP-2 (205),  
PTPbeta/zeta (206) 
plakoglobin v-Src (17) 
EGFR (189),  
VEGFR-2 (140),  
c-Met (138) 
SHP2 (200),  
PP2A (S/T) (191) 
DEP1 (143, 144),  
PTPkappa (201),  
PTP-LAR (202) 
p120ctn 
v-Src (17, 121),  
Fer (119, 135, 136),  
Fyn (119),  
Yes (119),  
GSK3beta (S/T) (125),  
CK1epsilon (S/T) (261),  
CK1alpha (S/T) (262) 
TrkA (139),  
c-Met (138, 139),  
EGFR (137),  
PDGFR (137),  
CSFR (137),  
VEGFR-2 (140) 
SHP2 (200),  
PKC2 (S/T) (133) 
DEP1 (143, 144),  
VEFGR-22 (S/T) (132), 
RPTPmu (145) 
1 Normal font denotes only phosphorylation or dephosphorylation; underlined enzymes denote both physical binding and 
(de)phosphorylation; italic denotes binding only; (S/T) denotes (de)phosphorylation on Ser or Thr residues. 2 denote kinases that 
activate phosphatases, most probably in an indirect way. 
 
Morpholino-mediated depletion of Kaiso in 
Xenopus embryos results in severe defects in both 
gastrulation and convergent extension, and these 
phenotypes can be rescued by re-expression of Kaiso (105, 
106). In contrast, Kaiso-deficient mice are viable (108). 
Although Kaiso acts as a genome wide transcriptional 
repressor in Xenopus embryos (109), gene expression is not 
increased in Kaiso-deficient mice (108). Kaiso is a member 
of a small protein family that contains two other Kaiso-like 
proteins, namely ZBTB4 (Kaiso-like 1) and ZBTB38 
(ZENON), which bind methylated DNA and act as 
transcriptional repressors (110). The discrepancy between 
the findings in mice and in Xenopus concerning the 
developmental requirement for Kaiso and its gene 
regulatory activity might be explained by functional 
redundancy of these Kaiso-like family members (99). 
Indeed, no ZBTB4 homolog could be indentified in 
Xenopus, which indicates that ZBTP4 might substitute for 
Kaiso in mouse but not in frog. 
 
6.2. p120ctn modulates signaling in the cytoplasm 
The work described above has outlined the role 
of p120ctn in the nucleus, which is to interfere with Wnt 
signaling.  Two recent reports point at interplay between 
p120ctn and the Wnt signaling pathway at cell junctions or 
in the cytoplasm (111, 112) (Figure 1B). A report by the 
McCrea group showed that p120ctn is targeted for 
proteasomal degradation via the same pathway as beta-
catenin (112). p120ctn degration involves a series of steps, 
including its association with axin and APC proteins, its 
phosphorylation by kinases of the CK1 family and by 
GSK3beta, and eventually its ubiquitination and 
proteasomal degradation. Only isoform 1 of p120ctn can 
associate with CK1alpha and GSK3beta, and it is prone to 
phosphorylation by these kinases, as well as to axin 
binding, ubiquitination, and proteasomal degradation (112). 
In the other report, p120ctn was shown to bind to 
CK1epsilon via an N-terminal domain (Figure 2) (111). 
This interaction domain is present in isoforms 1 and 3. 
CK1alpha can inhibit canonical Wnt signaling by 
destabilizing cytoplasmic beta-catenin, whereas 
CK1epsilon is activated upon Wnt triggering and 
contributes to stabilizing beta-catenin. In this model, 
p120ctn is required for the activation of CK1epsilon as it 
functions as an anchor protein to mediate the interaction of 
CK1epsilon with the Wnt receptor complex. Earlier, Frodo 
was found to physically link the p120ctn–Kaiso and beta-
catenin–TCF pathways by binding to both p120ctn and 
Dishevelled (Dsh) in the cytoplasm (113) (Figure 1B). 
Frodo acts upstream of both signaling pathways and 
stabilizes p120ctn (113). 
 
7. p120ctn AND PHOSPHORYLATION 
 
7.1. Phosphorylation of the cadherin–catenin complex 
Several lines of evidence suggest that cadherin-
based junctions, like integrin-mediated adhesion plaques, 
are regulated by phosphorylation (Figure 4). In fact, all 
members of the cadherin–catenin complex, except alpha-
catenin, are prone to phosphorylation on tyrosine (Tyr), 
serine (Ser) and threonine (Thr) by receptor tyrosine 
kinases (RTKs) and non-receptor protein kinases (Table 1). 
On the other hand, protein tyrosine phosphatases (PTPs) 
reverse this phosphorylation and allow dynamic protein 
modification in response to internal and external cues 
(reviewed in 114). The presence of multiple 
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phosphorylation sites in cadherins and catenins and the 
multitude of different kinases and phosphatases located at 
the membrane reveal the complexity of protein 
phosphorylation and its effects on adhesion. Tyr 
phosphorylation of cadherins and catenins has been studied 
extensively and is thought to modulate adhesive strength. 
The underlying mechanism is not clear and there is 
evidence for both a positive role and a negative role for Tyr 
phosphorylation.  
 
Phosphorylation affects the affinity between the 
components of the cadherin–catenin complex. 
Phosphorylation of Tyr residue Y654 in beta-catenin is 
important for binding to E-cadherin. Src-induced 
phosphorylation of this residue or introduction of a 
phosphomimetic mutation (Y654E) decreased the affinity 
between beta-catenin and E-cadherin and disrupted the 
cadherin-based junctions (Figure 4C, D) (115). Like E-
cadherin, N-cadherin does not bind Tyr-phosphorylated 
beta-catenin (116). The presence of p120ctn does not 
influence the binding of phosphorylated or 
unphosphorylated beta-catenin to E-cadherin (115). Beta-
catenin binds the acidic E-cadherin sequence at a long, 
positively charged groove; adding a negative charge in this 
groove by phosphorylation might disrupt intermolecular 
binding (117).  
 
Binding of beta-catenin to alpha-catenin involves 
29 AA in beta-catenin, only one of which is a Tyr, Y142 
(118). Alpha-catenin becomes uncoupled from beta-catenin 
upon phosphorylation of Y142 by the non-receptor Tyr 
kinase Fer or Fyn (but not by Src or Yes) as well as by 
using the tyrosine phosphatase inhibitor pervanadate (Fig 
4B, C) (119-121). Therefore, keeping Tyr residues Y142 
and Y654 of beta-catenin unphosphorylated is critical for 
the integrity of cadherin-based adhesion. 
 
PTP1B, a non-receptor tyrosine phosphatase, 
associates with N-cadherin and can dephosphorylate beta-
catenin; it can thereby stabilize cadherin-mediated adhesion 
(reviewed in 122). The binding of PTP1B to E-, VE- and 
N-cadherin (Table 1) requires phosphorylation of PTP1B 
on Tyr residue Y152 by Fer, which is recruited to the 
cadherin–catenin complex by binding to p120ctn (Figure 
4B) (123). Cell-permeable peptides that disrupt the Fer–
p120ctn interaction cause Fer to dissociate from N-cadherin 
complexes, after which PTP1B, beta-catenin and eventually 
p120ctn are lost (123). 
 
Tyr phosphorylation not only affects the binding 
efficacy of catenins but also determines the amount of 
membrane-localized E-cadherin. Src-mediated disruption 
of cell–cell contacts is accompanied by increased 
ubiquitination of E-cadherin, which causes its endocytosis 
(59). Src- or HGF-mediated Tyr phosphorylation of E-
cadherin on residues Y755 and Y756 (which are situated in 
the JMD) is a prerequisite for the binding of Hakai, an E3 
ubiquitin ligase. p120ctn binds to phosphorylated and 
unphosphorylated E-cadherin equally, but it has to compete 
with Hakai for binding to Tyr-phosphorylated E-cadherin 
(Figure 4D) (59).  
 
7.2. Phosphorylation of p120ctn  
Over the previous decade, the laboratory of 
Reynolds has been using two approaches to decipher how 
phosphorylation affects the diverse functions of p120ctn. In 
one approach, two-dimensional tryptic mapping allowed 
the identification of eight Tyr and eight Ser/Thr 
phosphorylation sites in p120ctn (Figure 2) (124, 125). A 
ninth Tyr phosphorylation site was identified by mutational 
analysis. In comparison with L-cells transformed with v-
Src and expressing wild type p120ctn and exogenous E-
cadherin, the Y217F mutation of p120ctn increased cell 
aggregation (121). All Tyr sites and most of the Ser and 
Thr sites are located in the N-terminal domain. Two 
phosphorylation sites, S879 and T916, flank the sequence 
encoded by the alternatively spliced exon A nearby the C-
terminus. S879 and T916 correspond to the previously 
reported S873 and T910, respectively (the new numbering 
is due to the inclusion of the six AA encoded by the 
alternatively used exon C). Remarkably, no 
phosphorylation sites are present in the Armadillo repeat 
domain. In the other aproach, panels of p120ctn phospho-
specific monoclonal antibodies were generated against 
specific phosphorylated Tyr, Ser and Thr residues in the 
p120ctn sequence context: Y228 (126), S879 (127), S268, 
S288, T310, and T916 (128). These antibodies have been 
helpful in identifying the p120ctn residues that are 
phosphorylated in response to EGF (126) or PDGF (129), 
namely Y228 and S879, respectively. 
 
In cells that were not transformed by Src, 
p120ctn was mainly phosphorylated on Ser, and to a minor 
extent on Thr and Tyr (124, 130, 131). Src-transformed 
cells have higher phosphotyrosine content, and mutating all 
eight Src-phosphorylation sites to Phe (p120ctn-8F) 
prevents Tyr phosphorylation of p120ctn and abolishes its 
binding to SHP-1 (124). Physiological Tyr phosphorylation 
of p120 occurs transiently in response to growth factor 
signaling and is rapidly terminated (126). In contrast, all 
Ser and Thr phosphorylation of p120ctn appears to be 
constitutive, with the exception of S879, which is 
phosphorylated by phorbol-ester-activated PKC (125) or 
PDGF-activated PKC-alpha (129). Basal Ser/Thr 
phosphorylation of p120ctn is transiently down-regulated in 
response to several cellular stimuli, such as VEGF (132) 
and PKC (133), and the inflammatory stimuli histamine 
(H1), thrombin and lysophosphatidic acid (LPA) (134). 
This downregulation is thought to modulate a variety of 
cadherin-associated activities, such as vascular 
permeability and leukocyte transcytosis. 
 
p120ctn, which was initially identified as a 
substrate for the non-receptor tyrosine kinase Src (9), is 
also phosphorylated by the Src-family members Fyn and 
Yes. Fyn interacts equally well with tyrosine-
phosphorylated and -unphosphorylated p120ctn (119). 
p120ctn is also a good substrate for the tyrosine kinase Yes, 
which interacts with p120ctn in an activation-dependent 
manner and subsequently activates Fer and Fyn (119) 
(Figure 4C). Tyrosine kinase Fer is constitutively 
associated with p120ctn (135, 136). The N-terminus of 
p120ctn serves as a docking protein facilitating interaction 
of Fer (and Fyn) with the cadherin–catenin complex 
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Figure 4. Constitutive tyrosine (Tyr) phosphorylation of the cadherin–catenin complex results in disassembly of junctions. (A) 
Src transformation, receptor Tyr kinase (RTK) signaling and protein phosphatase inhibition result in Tyr phosphorylation of 
cadherins and catenins, which leads to dissociation of adherent cell layers (left, blowup in B) into non-adherent spindle-shaped 
cells (right, blowup in C, D). Tyr phosphorylation in cadherin-based structures is abolished by kinase inhibition and upon 
junctional maturation and formation of confluent layers. (B) In adherent cells, p120ctn recruits the non-receptor Tyr kinase Fer to 
the cadherin–catenin complex, which activates the protein Tyr phosphatase PTP1B. Dephosphorylation of key Tyr residues Y142 
and Y654 in beta-catenin by PTP1B promotes junctional integrity. (C) The phosphorylation status of Y142 and Y654 in beta-
catenin can be shifted by growth factor signaling and by the activity of Src family members, which can be recruited by p120ctn. 
Phosphorylation of Y142 or Y654 in beta-catenin results in disassembly of, respectively, the beta-catenin–alpha-catenin and 
cadherin–beta-catenin complexes. (D) Dissociation of p120ctn from the cadherin tail results in removal of PTP1B and subsequent 
dissociation of cadherin-based junctions. The E3 ubiquitin ligase Hakai can now bind to phosphorylated Tyr residues Y755 and 
Y756 in the tail of E-cadherin, which results in its ubiquitination and internalization. EGFR: epidermal growth factor receptor. 
 
(Figure 4B). p120ctn-bound Fer can phosphorylate PTP1B 
on Y152, and this phosphorylation is essential for the 
binding of PTP1B to cadherin (123) (Figure 4D). In 
addition, p120ctn is phosphorylated in response to PDGF, 
CSF-1, EGF, NGF, HGF and VEGF (Table 1) (137-140).  
 
Tyr phosphorylation of p120ctn is transient, so a 
feedback mechanism must exist for reversing this 
phosphorylation. Indeed, several phosphatases have been 
reported to bind to and dephosphorylate p120ctn (Table 1). 
Src homology 2 (SH2) domain-containing protein tyrosine 
phosphatase 1 (SHP-1) binds to p120ctn following EGFR 
activation (141). SHP-1 is activated by Src-mediated 
phosphorylation at its C-terminus, and it very effectively 
dephosphorylates Src substrates, including phosphorylated 
Y296 of p120ctn (142). Experiments on substrate trapping 
mutants of receptor protein tyrosine phosphatase DEP1 
revealed that it interacts with p120ctn, as well as with beta-
catenin and plakoglobin (143, 144). p120ctn might interact 
with DEP1 in a phosphorylation-dependent manner, 
whereas beta-catenin and plakoglobin might interact with 
DEP1 constitutively (144). The receptor-like protein 
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tyrosine phosphatase RPTPmu specifically binds and 
dephosphorylates p120ctn (but not beta-catenin) 
independently of cadherins and of the phosphorylation 
status of p120ctn (145) (Table 1). The RPTPmu binding 
site in p120ctn is in the N-terminal domain, and deletion of 
AA 28–233 of p120ctn abrogates its interaction with 
RPTPmu (145). In conclusion, the N-terminus of p120ctn 
acts as a scaffold for many kinases and phosphatases that 
can interact with cadherin-bound p120ctn. In that way, 
p120ctn enables the modulation of the cadherin–catenin 
complex by phosphorylation. 
 
How does phosphorylation of p120ctn affect 
cadherin-based adhesion? In Src-transformed MDCK and 
L-cells, constitutive Tyr phosphorylation of p120ctn and 
beta-catenin weakens cadherin-based junctions (121, 146). 
Phosphorylation of p120ctn is dependent on its association 
with E-cadherin, as L-cells expressing an E-cadherin 
mutant lacking the cytoplasmic domain failed to 
phosphorylate p120ctn. Remarkably, membrane 
localization of p120ctn, but not via E-cadherin ligation per 
se, is essential for its susceptibility to phosphorylation on 
Ser or Thr residues. Chimeric cadherin-containing 
extracellular part of the IL-2R fused to the cytoplasmic 
cadherin part as well as CAAX anchoring of p120ctn 
localize p120ctn to the membrane and allow its 
phosphorylation in the absence of E-cadherin (147). 
Ser/Thr phosphorylation of p120ctn does not affect the 
p120ctn–cadherin binding affinity or cadherin complex 
stability, because mutating either of the Ser/Thr 
phosphorylation sites to Ala or mutating all six major 
Ser/Thr sites to Ala does not interfere with the capacity of 
this mutated p120ctn to rescue the phenotypes of p120ctn-
deficient cells (147). On the other hand, the presence of 
cadherin-bound beta-catenin is not essential for p120ctn 
phosphorylation, as a fusion of E-cadherin and alpha-
catenin is equally potent in phosphorylating p120ctn 
junctions (121, 146). In conclusion, increased Tyr 
phosphorylation of p120ctn leads to disruption of junctions, 
while constitutive Ser/Thr phosphorylation of p120ctn does 
not affect the integrity of adherens junctions. 
 
It is not clear how phosphorylation of p120ctn 
affects its binding to E-cadherin. Several groups reported 
that Tyr phosphorylation of p120ctn increases its binding 
affinity for E-cadherin (115, 135, 148-150). However, 
others found no change in binding affinity between E-
cadherin and p120ctn upon Src-mediated phosphorylation 
(17, 121). Increased binding of phosphorylated p120ctn to 
E-cadherin during junctional disassemby in Src-
transformed cells implies that p120ctn blocks the key 
residues for Hakai-binding (Y755 and Y756) (Figure 4C 
and D) and therefore that E-cadherin internalization is not 
mediated by ubiquitination. In contrast, phosphorylated 
p120ctn has also been reported to dissociate from E-
cadherin, and in this way it allows Hakai-mediated 
ubiquitination and endocytosis of E-cadherin (Figure 4D) 
(151). A recent report shows that CK1epsilon can be 
recruited to the cadherin–catenin complex, where it 
phosphorylates E-cadherin, resulting in the dissociation of 
p120ctn and beta-catenin from membrane-localized 
cadherins (111). 
7.3. p120ctn isoforms and phosphorylation 
Alternative splicing determines the extent of 
phosphorylation of different p120ctn isoforms by 
restricting the number of available phosphorylation sites or 
by allowing isoform-specific binding of kinases and 
phosphatases. The N-terminal domain of p120ctn is 
essential for its phosphorylation, and different p120ctn 
isoforms that can be generated from the four translation 
initiation sites exhibit different truncations of this N-
terminal domain (Figure 2). p120ctn isoform 1 has the 
longest N-terminal domain and contains all the Tyr, Ser and 
Thr sites that can be phosphorylated. p120ctn isoform 3 
lacks the first Tyr residue (Y96), which is present only in 
the long isoforms. p120ctn isoform 4 is translated from the 
fourth translation initiation site and lacks almost the entire 
N-terminal domain, including all nine Tyr sites and six of 
the Ser and Thr sites. Hence, p120ctn isoform 4 is not 
regulated by phosphorylation and can be viewed as a 
dominant-negative p120ctn variant for several functions.  
 
Besides the role of isoforms in determining the 
potential phosphorylation sites, some kinases and 
phosphatases preferentially bind to certain p120ctn 
isoforms. The Fer binding domain in p120ctn is confined to 
a 26-AA region (131 to 156) present in both long and short 
isoforms (123). p120ctn interacts with tyrosine kinase Fer 
in Rat-2 embryonic fibroblasts and in epithelial A431 cells. 
Although both cell types express long and short isoforms, 
Fer predominantly binds and phosphorylates long isoforms 
(135, 136). Different isoforms of p120ctn interact to 
different extents with the tyrosine phosphatase SHP-1, and 
this seems to be partly related to their susceptibility to 
EGF-dependent phosphorylation (141). p120ctn isoform 
3A is efficiently phosphorylated on Tyr in response to EGF 
stimulation and binds SHP-1 strongly. Although p120ctn 
isoform 1A contains all Tyr phosphorylation sites, 
including the EGF-specific phosphorylation site Y228, it is 
less efficiently phosphorylated upon EGF stimulation and 
interacts more weakly with SHP-1. As both p120ctn 
isoforms 1A and 3A contain Y228, it is strange that they 
are phosphorylated to different degrees upon EGF 
triggering. p120ctn isoform 1A can probably dock an 
additional phosphatase via its exclusive Y96 site, which 
would diminish its overall Tyr phosphorylation. p120ctn 
isoform 4A has no Tyr phosphorylation sites at all and 
interacts with SHP-1 very weakly. Remarkably, the 
presence of six AA encoded by the alternatively spliced 
exon C leads to a strong reduction in both Tyr 
phosphorylation and SHP-1 binding (141). RPTPmu 
interacts with p120ctn isoform 1A but fails to bind to a 
mutant lacking much of the N-terminus (145). However, 
whether the natural long and short p120ctn isoforms have 
different binding capacities for RPTPmu has not been 
tested.  
 
8. p120ctn IN DEVELOPMENT  
 
The role of p120ctn has been investigated in 
several animal model systems (reviewed in 152, 153). 
Although C. elegans and Drosophila have each only one 
p120ctn subfamily member (JAC-1 and Drosphila 
p120ctn), genetic or RNAi-mediated reduction of p120ctn 
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levels in C. elegans and Drosophila does not affect normal 
development (154-156). In contrast, RNAi-mediated 
depletion of both zygotic and maternal p120ctn in 
Drosophila embryos results in severe morphogenetic 
defects (73). Except for the findings in the latter report, it 
seems that p120ctn is not required for normal development 
in invertebrates. 
 
In frog, proper p120ctn levels need to be 
maintained throughout development, because 
overexpression or knockdown of p120ctn in Xenopus 
embryos leads to severe embryonal abnormalities. Induced 
expression of murine p120ctn isoform 1A or 1N during 
Xenopus development leads to gastrulation defects and 
head malformation (157, 158). On the other hand, 
morpholino-mediated p120ctn knockdown in Xenopus 
results in severe developmental defects; the nature of the 
defects depended on which cells of early cleavage embryos 
were injected with morpholinos (46, 47).  
 
Also in mice, proper p120ctn levels are a 
prerequisite for normal development, and embryos with 
total knockout of p120ctn die in utero (mentioned in 50, 
54). In addition, several tissue-specific p120ctn knockouts 
generated by using the Cre/LoxP system have been 
reported. Two types of floxed p120ctn alleles have been 
generated. In one of them, p120ctn exons 3 to 8, encoding 
all four possible start codons (M1-4), were flanked by LoxP 
sites to prevent any natural initiation of translation after 
Cre-mediated recombination (50). In the other approach, 
exon 7 of p120ctn was floxed, and Cre-mediated 
recombination resulted in a frameshift leading to 
degradation of mRNA by non-sense mediated decay (53). 
Crossing these p120ctn floxed mice with mice in which the 
Cre-recombinase is controlled by a tissue-specific promoter 
resulted in specific depletion of p120ctn in salivary gland 
(50), skin (49, 159), teeth (51), dorsal forbrain (53), 
intestine (52), endothelial cells (54), oral cavity, esophagus 
and forestomach (160). Though these conditional p120ctn 
knockout mice have a wide range of tissue-specific 
phenotypes (reviewed in 152, 153), reduction of cadherin 
levels seems to be a common underlying mechanism. In 
these studies, the requirement for p120ctn during 
development turned out to depend to a large degree on the 
time at which the Cre recombinase is expressed. For 
instance, Cre-mediated ablation of p120ctn in endothelial 
tissues at 7.5 dpc causes death at 11.5 dpc (54). In other 
studies, developmental defects in tissue-specific p120ctn 
knockouts are mostly avoided by employing Cre-lines that 
are expressed near the end of embryonic development. 
Nevertheless, ablating p120ctn after midgestation in 
salivary gland and intestine can still result in perinatal 
death (50, 52), whereas its ablation in the skin, teeth or 
dorsal forebrain does not affect viability (49, 51, 53).  
 
9. p120ctn AND CANCER 
 
9.1. Altered expression of p120ctn in tumors 
The expression pattern of p120ctn is abberant in a 
wide range of human tumors (reviewed in 161, 162). In 
general, p120ctn is either absent or altered in most human 
tumors, and its derangement is often correlated with poor 
prognosis. Alterations in p120ctn expression include 
decreased levels and translocation to the cytoplasm, and 
occasionally to the nucleus. p120ctn can act as a proto-
oncogene or as an invasion suppressor, depending on the 
order in which p120ctn and E-cadherin are down-regulated. 
Loss of p120ctn results in decreased E-cadherin levels, and 
E-cadherin is indeed frequently down-regulated in 
epithelial cancers, in which it acts as a tumor-suppressor 
(163, 164). Downregulation of p120ctn in tumors cannot be 
fully explained by genetic inactivation because so far only 
a few mutations in the CTNND1 gene have been reported 
and only in breast cancer (165) and in the SW48 colon 
carcinoma cell line (15). Perhaps other mechanisms are 
involved in p120ctn downregulation in tumors, such as 
transcriptional downregulation, epigenetic modification, or 
microRNA-mediated silencing, but this has not been 
properly documented. One study reported that p120ctn is 
transcriptionally downregulated by FOXC2 in non-small 
cell lung cancer cells (NSCLC) (166). FOXC2 binds to the 
p120ctn promoter and reduces its activity.  RNAi-mediated 
silencing of FOXC2 increases p120ctn promoter activity as 
well as p120ctn and E-cadherin levels (166). On the other 
hand, E-cadherin loss results in translocation of p120ctn to 
the cytoplasm, where it modulates RhoGTPases in a way 
that favors cell motility.  
 
Cytoplasmic p120ctn can regulate several 
processes involved in tumorigenesis, such as cell 
proliferation, motility, invasion, anchorage-independent 
growth, and inflammation. p120ctn can either stimulate or 
inhibit cell proliferation and tumor growth. Expression of 
p120ctn promotes transformed growth of both E-cadherin-
negative and -positive cells (43, 82). On the other hand, 
knockdown of p120ctn in E-cadherin-negative cells reduces 
the growth rate, as evidenced by a reduction in the 
proportion of cells in the S-phase and by decreased MAPK 
signaling (82). In E-cadherin-positive breast cancer cells, 
p120ctn depletion results in increased proliferation and 
activation of Ras-MAPK signaling (82). In addition, 
expression of p120ctn isoform 3 in E-cadherin-positive 
cells blocks cell proliferation, DNA synthesis and in vivo 
tumor growth (64, 89).  
 
Several p120ctn knockdown studies have 
illustrated that p120ctn is important for cell migration and 
invasion. Cells devoid of p120ctn failed to repopulate the 
wounded area in a scratch assay (79). On the other hand, 
stable knockdown of p120ctn in E-cadherin-deficient cells 
resulted in decreased migration and invasiveness (45). In 
clear renal cell carcinomas, E-cadherin is downregulated 
and p120ctn is translocated to the cytoplasm. Furthermore, 
p120ctn undergoes an isoform switch from predominantly 
short to long p120ctn isoforms. This switch is correlated 
with micrometastasis, which indicates that p120ctn isoform 
1 simulates invasiveness in vivo, at least in this type of 
cancer (80). In contrast, p120ctn can also block invasion, 
because p120ctn depletion in lung cancer cell lines 
enhances invasion and metastasis due to differential 
regulation of RhoGTPase activity (90). p120ctn also acts as 
a proto-oncogene by relieving the Kaiso-mediated 
repression of beta-catenin target genes, such as c-Fos, Myc, 
Ccnd1 (encodes Cyclin D1) and Mmp7 (encodes 
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Matrylisin) (105, 107), and this favors tumor formation and 
invasion. 
 
The role of p120ctn in cancer was further 
investigated in animal models. Ablation of p120ctn in 
salivary gland resulted in morphological abnormalities 
closely resembling high-grade intraepithelial neoplasia, but 
it did not result in cancer (50). Ablation of p120ctn in skin 
caused hyperproliferation (49) and p120ctn-deficient skin 
grafts displayed signs of epidermal hyperkeratosis and 
dysplastic keratinocytes (159). Recently, p120ctn was 
deleted from the oral cavity, esophagus and forestomach 
(160). The mutant animals survived, and by 4 to 6 months 
of age most of them had developed precancerous lesions. 
By the age of 9 to 12 months, 70% of them had developed 
tumors. None of the control littermates developed cancer. 
This confirmed that p120ctn is a tumor suppressor gene. 
The tumors in this mouse model closely resemble human 
oral squamous cell cancers and esopahgeal cell cancers, 
and this model might thus be useful for development of 
early detection strategies and novel therapies. 
 
9.2. p120ctn in inflammation and cancer  
The signaling pathways involved in cancer and 
inflammation are interconnected (167). Indeed, poorly 
differentiated human squamous cell carcinomas also 
showed nuclear NF-κB and perturbed expression and/or 
localization of p120ctn (159). p120ctn depletion in mouse 
skin caused hyperproliferation and chronic inflammation 
due to increased NF-κB activation (49). Both general 
immunosuppresive drugs (dexamethasone) and a NF-κB 
inhibitior (IKK2 inhibitor) reduced the hyperproliferation 
in p120ctn-deficient skin grafts (49, 159). NF-κB activation 
in p120ctn-depleted keratinocytes is dependent on RhoA 
activity. Constitutively active RhoA and ROCK mutations 
result in nuclear translocation of NF-κB in wild-type 
keratinocytes, whereas nuclear NF-κB expression can be 
reverted in p120ctn-deficient keratinocytes by expression 
of dominant-negative RhoA and by treatment with a ROCK 
inhibitor (49). Moreover, nuclear NF-κB can also be 
reverted by introducing a cadherin-uncoupled p120ctn 
mutant, but not by a RhoA-uncoupled mutant (delta622-
628) (49). Finally, genetic ablation of intestinal p120ctn 
also results in increased infiltration of COX-2-positive 
neutrophils, which is commonly seen in inflammatory 
bowel disease (52). This disease predisposes intestinal 
tissue to cancer (168). The tumor cells that develop in mice 
with conditional loss of p120ctn in the oral cavity, 
esophagus and squamous forestomach secrete 
inflammatory signals that lead to immune cell infiltration 
(160). Blocking the recruitment of immune cells with 
dexamethasone resulted in hyperplasia but not in 
desmoplasia or inflammation. 
 
Toll-like receptors (TLRs) are key elements of 
the innate immune system. These receptors recognize 
bacterial lipopolysaccharide (LPS) and trigger the induction 
of immunoregulatory chemokines and cytokines. When 
TLR4 binds LPS, it activates the MyD88-dependent and 
MyD88-independent pathways. The MyD88-dependent 
pathway, which is triggered by all TLRs except TLR3, 
activates NF-κB and activator protein-1 (AP-1). This leads 
to the induction of proinflammatory chemokines and 
cytokines, such as Tumour-Necrosis-Factor α and 
interleukin-1β. Recently, Wang et al. (169) showed that 
p120ctn modulates innate immune function in the lung by 
disrupting the association of TLR4 with MyD88 and 
thereby blocking TLR4 signaling and NF-κB activation in 
endothelial cells. 
 
9.3. p120ctn isoforms in EMT and cancer 
A switch in p120ctn isoforms has been observed 
during epithelial-to-mesenchymal transition (EMT). EMT 
is an orchestrated series of events that allows epithelial 
sheets to dissociate, lose cell-cell interactions and cell-
extracellular matrix interactions, and reorganize the 
cytoskeleton and transcriptional program in order to induce 
a mesenchymal phenotype (170). During EMT, E-cadherin 
downregulation in epithelial cells is accompanied by 
upregulation of mesenchymal cadherins (e.g. N-cadherin), 
a phenomenon called cadherin switching (171). 
Interestingly, a switch from short to long p120ctn isoforms 
has been observed during the EMT induced by expression 
of c-Fos (20), Snail (21), SIP1/ZEB2 (22, 23), E47 (23), 
Slug (23), Twist (24) or Zeppo1 (25). The downregulation 
of short ‘epithelial’ p120ctn isoforms during EMT is due to 
decreased expression of epithelial splicing regulatory 
proteins 1 and 2 (ESRP1 and ESRP2), which favors 
skipping of exon 3 (encoding the first two translation 
initiation sites) and initiation of translation from the third 
start codon (encoded by exon 5) (24). Also, Src 
transformation of MDCK cells induces an EMT-like 
process (172) associated with a switch from short to long 
p120ctn isoforms (14). This switch during EMT is 
consistent with the expression of long and short p120ctn 
isoforms in fibroblasts and epithelial cell types, 
respectively. Re-expression of E-cadherin in Snail-induced 
mesenchymal cells failed to restore the epithelial 
morphology and the expression of ‘epithelial’ short 
p120ctn isoforms (21). This confirms that the abundance of 
the different p120ctn isoforms is regulated by cell type-
specific splice factors and not necessarily by the expression 
of certain cadherin types (24). In contrast, the p120ctn 
isoform switch was not observed during EMT induced in 
highly differentiated colon cancer cells by TGF-beta and 
TNF-alpha (81). This discrepancy might be explained by 
the expression of long p120ctn isoforms in non-induced 
cells at high levels that cannot be augmented further during 
EMT (81).  
 
 During tumor progression, primary tumor cells 
also undergo an EMT-like process to break away from the 
primary tumor, enter blood or lymphatic vessels, and form 
metastises at secondary sites. EMT-like processes have 
been observed during progression of prostate carcinoma 
and in anaplastic thyroid carcinomas, and their occurrence 
coincides with a switch from short to long p120ctn 
isoforms and from E- to N-cadherin (173, 174). Forced 
expression of E-cadherin in the pancreatic carcinoma cell 
line MIA PaCa-2 restored the epithelial phenotype and 
suppressed cell migration and invasion, but forced 
expression of N-cadherin did not have the same effect 
(175). Interestingly, E-cadherin bound predominantly to 
unphosphorylated p120ctn isoform 3, whereas tyrosine-
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phosphorylated p120ctn isoform 1 interacted exclusively 
with N-cadherin (175). However, no p120ctn isoform 
switch could be observed during tumor progression from 
benign (immortalized human keratinocytes) to malignant 
epithelial skin tumors (SCCs). In lung SCCs and 
adenocarcinomas, abnormal expression of p120ctn, 
including downregulation of both long and short isoforms, 
is associated with tumor progression and poor prognosis 
(176). E-cadherin and p120ctn isoform 3 are expressed in 
normal bronchial epithelium, but p120ctn isoform 1 is 
upregulated and localized in the cytoplasm of squamous 
cell lung cancers and lung adenocarcinomas (179). Further 
analysis revealed that overexpression of p120ctn isoform 1 
mRNA correlates significantly with abnormal E-cadherin 
expression, lymph node metastasis, and poor differentiation 
(177). Another study confirmed a significant reduction of 
both long and short p120ctn isoforms in lung carcinomas 
compared to normal lung tissues (178). In summary, 
although EMT-like processes can occur during tumor 
progression in some tumor types, this is not a common 
feature in all cancers, as might be expected in view of the 
heterogenous nature of cancer. 
 
Very little is known about the effects of the 
alternatively spliced internal exons of p120ctn during 
tumorigenesis. Exon B encodes a NES and is expressed in 
some human tissues, such as kidney, pancreas, colon, small 
intestine and prostate. Interestingly, expression of exon B is 
lost in the corresponding tumorigenic tissues (78), 
suggesting that during tumor progression p120ctn is shifted 
towards the nucleus, which might then relieve the Kaiso-
mediated repression of oncogenic target genes. 
 
10. THE p120ctn FAMILY 
 
What complicates matters even more is that 
p120ctn does not act alone. In vertebrates, and particularly 
in mammals, the diversity of the p120ctn family has 
increased throughout evolution. This has led to the 
emergence of two evolutionarily conserved clusters: the 
p120ctn clade consisting of p120ctn and ARVCF 
(Armadillo Repeat gene deleted in Velo-Cardio-Facial 
syndrome), and the delta-catenin clade, consisting of p0071 
(plakophilin-4) and delta-catenin (neural plakophilin-
related armadillo protein or NPRAP or neurojungin) (152, 
179). The four p120ctn family members have similar 
overall structures, with a central Armadillo repeat domain 
containing nine Armadillo repeats (12, 13). This central 
domain enables all p120ctn subfamily members to bind the 
JMD of classical cadherins (40, 180-184). We have 
recently reviewed the structures and functions of the other 
family members in comparison with p120ctn (153).  
 
When ARVCF and delta-catenin are 
overexpressed in, respectively, MDCK and CWR22Rv-1 
prostate cancer cells, they can compete with p120ctn for 
JMD binding (181, 185). Also they can restore cadherin-
based junctions in p120ctn-depleted cells (42). However, 
Zhang et al. (186) showed in two lung cancer cell lines that 
overexpressed delta-catenin binds to the cytoplasmic 
domain of E-cadherin in a way that is non-competitive with 
p120ctn. Competitive binding to E-cadherin might thus 
occur only in certain cell types. Moreover, endogenous 
ARVCF and delta-catenin fail to stabilize classical 
cadherins in tissue-specific p120ctn knock-out mice (49, 
50, 52). So, at endogenous levels, apparently none of the 
p120ctn family members can substitute for p120ctn. Of 
course, crossing mouse lines in which knock-out of 
individual p120ctn family members was not lethal should 
provide more information about redundancy. For example, 
mating mice with a total knock-out of ARVCF (mentioned 
in 152) with mice in which p120ctn is deleted specifically 
in the skin (49) might reveal whether ARVCF and p120ctn 
do not substitute at all for each other. Another approach to 
assess the extent of functional overlaps amongst p120ctn 
family members is to evaluate the consequence of 
knocking-in the coding region of one family member into 
the genetic locus of another.  
 
11. CONCLUSIONS AND PERSPECTIVES 
 
In this review we focused on the new insights 
into the molecular mechanisms of the diverse functions of 
p120ctn. Like beta-catenin, p120ctn plays key roles at cell–
cell junctions and in intracellular signaling. At the cell 
membrane, p120ctn regulates cadherin stability and 
trafficking. p120ctn binds newly synthesized N-cadherin, 
and together they are transported to the membrane. In 
contrast, p120ctn binds to E-cadherin only after it is 
transported to the membrane. Thus, p120ctn is recruited to 
different cadherins at different time points in their 
biogenesis. What is even more intriguing is that p120ctn 
can stabilize both N-cadherin and E-cadherin to similar 
extents but seemingly by different mechanisms. For 
instance, p120ctn blocks two tyrosine phosphorylation sites 
in the JMD that are important for Hakai-mediated 
endocytosis of E-cadherin. This mechanism is specific for 
E-cadherin, because Hakai does not bind to N-cadherin.   
 
 Recent findings revealed a high degree of 
interconnectedness between p120ctn/Kaiso and beta-
catenin/TCF signaling. In the cytoplasm, these pathways 
are physically linked to each other by a protein called 
Frodo. Also, p120ctn and beta-catenin are targeted for 
proteasomal degradation via the same pathway. In the 
nucleus, p120ctn can induce gene expression by inhibiting 
the transcriptional repression of Kaiso, whereas beta-
catenin induces expression by acting as a co-activator. 
Moreover, in the nucleus there is cross-talk between the 
p120ctn/Kaiso and beta-catenin/TCF signaling pathways, 
which share some target genes. These commonly regulated 
genes can be activated by nuclear beta-catenin and 
repressed by Kaiso. p120ctn can block this Kaiso-mediated 
repression by an unknown mechanism. Live cell imaging in 
combination with fluorescence resonance energy transfer 
(FRET) might give some hints about where p120ctn and 
Kaiso interact. In addition, we need to gain insight into 
where and when the p120ctn/Kaiso pathway is activated. 
This would give us a better understanding of the 
importance of this pathway relative to the beta-catenin/TCF 
signaling pathway. 
 
A heavily discussed function of p120ctn in the 
cytoplasm is its influence on the activity of RhoGTPases. 
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p120ctn mediates inhibition of RhoA and activation of both 
Rac1 and Cdc42, possibly via an interaction between 
p120ctn and RhoA or by one of the other mechanisms 
discussed in section 5. It is becoming increasingly clear that 
the effect of p120ctn on RhoGTPase activity is cell-type 
specific. Moreover, all that we know about p120ctn 
modulation of RhoGTPase signaling is based on the use of 
‘classic’ Rho GTPase tools that do not faithfully reflect the 
degree of regulation (187). These tools include dominant-
positive and -negative mutants of the three major Rho 
GTPases: Rac1, Cdc42 and RhoA. Another is the 
biochemical pulldown assay, which measures the average 
activation status of a given GTPase in a population of cells. 
However, new imaging technologies allow visualization of 
Rho GTPase signaling with high spatio-temporal resolution 
(187). This kind of visualization is expected to resolve 
many controversial results reported in the literature and to 
provide the information needed to understand how p120ctn 
modulates RhoGTPase activity at cell–cell junctions and at 
intracellular locations. 
 
The complexity of p120ctn research is increased 
by phosphorylation and alternative splicing events. 
Phosphorylation affects several functions of p120ctn, such 
as modulation of the strength and composition of cadherin-
based junctions and determination of the binding affinity 
between p120ctn and RhoA. Resolving all phosphorylation 
events in time and space is nearly impossible, but it has 
become clear over recent years that p120ctn is important 
both as a substrate and as a scaffold for kinases and 
phosphatases. In addition, accumulating evidence indicates 
that the different splice variants of p120ctn have specific 
functions and can be targeted to different subcellular 
compartments.  
 
p120ctn performs pleiotrophic functions in 
several cell compartments. This is clearly true for its effect 
on signaling. These varied functions lead us to believe that 
the p120ctn proteins are important during development and 
that disturbance of the levels of different isoforms can 
influence cancer development. It is fairly clear that p120ctn 
influences the initiation, growth and metastasis of cancer. 
Moreover, an association between the development of 
cancer and inflammation has been known for a long time 
(188). As targeted ablation of p120 results in a “cytokine 
storm” and intense inflammation, it is believed that p120ctn 
functions as a potent suppressor of inflammation. Recently, 
p120ctn has been described as a tumor suppressor gene 
(160). Future studies will have to unravel how the different 
functions of p120ctn participate in normal development and 
in disease. 
 
12. ACKNOWLEDGEMENTS 
 
This work was supported by grants from the 
Queen Elisabeth Medical Foundation (G.S.K.E.), Belgium, 
and from the Geconcerteerde Onderzoeksacties of Ghent 
University. Tim Pieters has been supported by the Instituut 
voor de Aanmoediging van Innovatie door Wetenschap en 
Technologie in Vlaanderen (IWT). We acknowledge Dr. 
Amin Bredan for critical reading of the manuscript, and the 
members of our research group for valuable discussions. 
13. REFERENCES  
 
1.    K. Matter and M. S. Balda: Signalling to and from tight 
junctions. Nat Rev Mol Cell Biol 4, 225-236 (2003) 
 
2.    A. Hartsock and W. J. Nelson: Adherens and tight 
junctions: Structure, function and connections to the actin 
cytoskeleton. Biochim Biophys Acta - Biomembranes 1778, 
660-669 (2008) 
 
3.    E. Delva, D. K. Tucker and A. P. Kowalczyk: The 
desmosome. Cold Spring Harb Perspect Biol 1, a002543 
(2009) 
 
4.    K. J. Green and C. A. Gaudry: Are desmosomes more than 
tethers for intermediate filaments? Nat Rev Mol Cell Biol 1, 
208-216 (2000) 
 
5.    D. A. Goodenough and D. L. Paul: Gap junctions. Cold 
Spring Harb Perspect Biol 1, a002576 (2009) 
 
6.    P. Hulpiau and F. van Roy: Molecular evolution of the 
cadherin superfamily. Int J Biochem Cell Biol 41, 349-369 
(2009) 
 
7.    F. van Roy and G. Berx: The cell-cell adhesion molecule 
E-cadherin. Cell Mol Life Sci 65, 3756-3788 (2008) 
 
8.    W. Meng and M. Takeichi: Adherens junction: molecular 
architecture and regulation. Cold Spring Harb Perspect Biol 1, 
a002899 (2009) 
 
9.    A. B. Reynolds, D. J. Roesel, S. B. Kanner and J. T. 
Parsons: Transformation-specific tyrosine phosphorylation of a 
novel cellular protein in chicken cells expressing oncogenic 
variants of the avian cellular src gene. Mol Cell Biol 9, 629-
638 (1989) 
 
10.    A. Keirsebilck, S. Bonne, K. Staes, J. van Hengel, F. 
Nollet, A. Reynolds and F. van Roy: Molecular cloning of the 
human p120ctn catenin gene (CTNND1): expression of 
multiple alternatively spliced isoforms. Genomics 50, 129-146 
(1998) 
 
11.    S. Aho, K. Rothenberger and J. Uitto: Human p120ctn 
catenin: tissue-specific expression of isoforms and molecular 
interactions with BP180/type XVII collagen. J Cell 
Biochem 73, 390-399 (1999) 
 
12.    H. J. Choi and W. I. Weis: Structure of the armadillo 
repeat domain of plakophilin 1. J Mol Biol 346, 367-376 
(2005) 
 
13.    N. Ishiyama, S. H. Lee, S. Liu, G. Y. Li, M. J. Smith, 
L. F. Reichardt and M. Ikura: Dynamic and static 
interactions between p120 catenin and E-cadherin regulate 
the stability of cell-cell adhesion. Cell 141, 117-128 (2010) 
 
14.    Y. Y. Mo and A. B. Reynolds: Identification of 
murine p120 isoforms and heterogeneous expression of 
p120cas isoforms in human tumor cell lines. Cancer Res 
56, 2633-2640 (1996) 
Functions of p120ctn isoforms 
15.    R. C. Ireton, M. A. Davis, J. van Hengel, D. J. 
Mariner, K. Barnes, M. A. Thoreson, P. Z. Anastasiadis, L. 
Matrisian, L. M. Bundy, L. Sealy, B. Gilbert, F. van Roy 
and A. B. Reynolds: A novel role for p120 catenin in E-
cadherin function. J Cell Biol 159, 465-476 (2002) 
 
16.    J. M. Staddon, C. Smales, C. Schulze, F. S. Esch and 
L. L. Rubin: p120, a p120-related protein (p100), and the 
cadherin/catenin complex. J Cell Biol 130, 369-381 (1995) 
 
17.    A. B. Reynolds, J. Daniel, P. D. McCrea, M. J. 
Wheelock, J. Wu and Z. Zhang: Identification of a new 
catenin: the tyrosine kinase substrate p120cas associates 
with E-cadherin complexes. Mol Cell Biol 14, 8333-8342 
(1994) 
 
18.    N. Golenhofen and D. Drenckhahn: The catenin, 
p120ctn, is a common membrane-associated protein in 
various epithelial and non-epithelial cells and tissues. 
Histochem Cell Biol 114, 147-155 (2000) 
 
19.    O. Montonen, M. Aho, J. Uitto and S. Aho: Tissue 
distribution and cell type-specific expression of p120ctn 
isoforms. J Histochem Cytochem 49, 1487-1496 (2001) 
 
20.    A. Eger, A. Stockinger, B. Schaffhauser, H. Beug and 
R. Foisner: Epithelial mesenchymal transition by c-Fos 
estrogen receptor activation involves nuclear translocation 
of beta-catenin and upregulation of beta-catenin/lymphoid 
enhancer binding factor-1 transcriptional activity. J Cell 
Biol 148, 173-188 (2000) 
 
21.    T. Ohkubo and M. Ozawa: The transcription factor 
Snail downregulates the tight junction components 
independently of E-cadherin downregulation. J Cell Sci 
117, 1675-1685 (2004) 
 
22.    C. Vandewalle, J. Comijn, B. De Craene, P. 
Vermassen, E. Bruyneel, H. Andersen, E. Tulchinsky, F. 
Van Roy and G. Berx: SIP1/ZEB2 induces EMT by 
repressing genes of different epithelial cell-cell junctions. 
Nucleic Acids Res 33, 6566-6578 (2005) 
 
23.    D. Sarrio, B. Perez-Mies, D. Hardisson, G. Moreno-
Bueno, A. Suarez, A. Cano, J. Martin-Perez, C. Gamallo 
and J. Palacios: Cytoplasmic localization of p120ctn and E-
cadherin loss characterize lobular breast carcinoma from 
preinvasive to metastatic lesions. Oncogene 23, 3272-3283 
(2004) 
 
24.    C. C. Warzecha, T. K. Sato, B. Nabet, J. B. 
Hogenesch and R. P. Carstens: ESRP1 and ESRP2 are 
epithelial cell-type-specific regulators of FGFR2 splicing. 
Mol Cell 33, 591-601 (2009) 
 
25.    E. M. Slorach, J. Chou and Z. Werb: Zeppo1 is a 
novel metastasis promoter that represses E-cadherin 
expression and regulates p120-catenin isoform expression 
and localization. Genes Dev 25, 471-484 (2011) 
 
26.    C. C. Warzecha, P. Jiang, K. Amirikian, K. A. 
Dittmar, H. Lu, S. Shen, W. Guo, Y. Xing and R. P. 
Carstens: An ESRP-regulated splicing programme is 
abrogated during the epithelial-mesenchymal transition. 
EMBO J 29, 3286-3300 (2010) 
 
27.    J. van Hengel, P. Vanhoenacker, K. Staes and F. van 
Roy: Nuclear localization of the p120(ctn) Armadillo-like 
catenin is counteracted by a nuclear export signal and by 
E-cadherin expression. Proc Natl Acad Sci U S A 96, 
7980-7985 (1999) 
 
28.    D. M. Bryant and J. L. Stow: The ins and outs of 
E-cadherin trafficking. Trends Cell Biol 14, 427-434 
(2004) 
 
29.    E. Delva and A. P. Kowalczyk: Regulation of 
cadherin trafficking. Traffic 10, 259-267 (2009) 
 
30.    K. C. Miranda, T. Khromykh, P. Christy, T. L. Le, 
C. J. Gottardi, A. S. Yap, J. L. Stow and R. D. Teasdale: 
A dileucine motif targets E-cadherin to the basolateral 
cell surface in Madin-Darby canine kidney and LLC-
PK1 epithelial cells. J Biol Chem 276, 22565-22572 
(2001) 
 
31.    Y. T. Chen, D. B. Stewart and W. J. Nelson: 
Coupling assembly of the E-cadherin/beta-catenin 
complex to efficient endoplasmic reticulum exit and 
basal-lateral membrane targeting of E-cadherin in 
polarized MDCK cells. J Cell Biol 144, 687-699 (1999) 
 
32.    K. C. Miranda, S. R. Joseph, A. S. Yap, R. D. 
Teasdale and J. L. Stow: Contextual binding of p120ctn 
to E-cadherin at the basolateral plasma membrane in 
polarized epithelia. J Biol Chem 278, 43480-43488 
(2003) 
 
33.    M. A. Thoreson, P. Z. Anastasiadis, J. M. Daniel, 
R. C. Ireton, M. J. Wheelock, K. R. Johnson, D. K. 
Hummingbird and A. B. Reynolds: Selective uncoupling 
of p120(ctn) from E-cadherin disrupts strong adhesion. J 
Cell Biol 148, 189-202 (2000) 
 
34.    J. K. Wahl, 3rd, Y. J. Kim, J. M. Cullen, K. R. 
Johnson and M. J. Wheelock: N-cadherin-catenin 
complexes form prior to cleavage of the proregion and 
transport to the plasma membrane. J Biol Chem 278, 
17269-17276 (2003) 
 
35.    S. Mary, S. Charrasse, M. Meriane, F. Comunale, 
P. Travo, A. Blangy and C. Gauthier-Rouviere: 
Biogenesis of N-cadherin-dependent cell-cell contacts in 
living fibroblasts is a microtubule-dependent kinesin-
driven mechanism. Mol Biol Cell 13, 285-301 (2002) 
 
36.    X. Chen, S. Kojima, G. G. Borisy and K. J. Green: 
p120 catenin associates with kinesin and facilitates the 
transport of cadherin-catenin complexes to intercellular 
junctions. J Cell Biol 163, 547-557 (2003) 
 
37.    M. Yanagisawa, I. N. Kaverina, A. Wang, Y. 
Fujita, A. B. Reynolds and P. Z. Anastasiadis: A novel 
interaction between kinesin and p120 modulates p120 
Functions of p120ctn isoforms 
localization and function. J Biol Chem 279, 9512-9521 
(2004) 
 
38.    A. Roczniak-Ferguson and A. B. Reynolds: 
Regulation of p120-catenin nucleocytoplasmic shuttling 
activity. J Cell Sci 116, 4201-4212 (2003) 
 
39.    T. Ichii and M. Takeichi: p120-catenin regulates 
microtubule dynamics and cell migration in a cadherin-
independent manner. Genes Cells 12, 827-839 (2007) 
 
40.    A. S. Yap, C. M. Niessen and B. M. Gumbiner: The 
juxtamembrane region of the cadherin cytoplasmic tail 
supports lateral clustering, adhesive strengthening, and 
interaction with p120ctn. J Cell Biol 141, 779-789 (1998) 
 
41.    M. Peifer and A. S. Yap: Traffic control: p120-
catenin acts as a gatekeeper to control the fate of classical 
cadherins in mammalian cells. J Cell Biol 163, 437-440 
(2003) 
 
42.    M. A. Davis, R. C. Ireton and A. B. Reynolds: A core 
function for p120-catenin in cadherin turnover. J Cell Biol 
163, 525-534 (2003) 
 
43.    M. R. Dohn, M. V. Brown and A. B. Reynolds: An 
essential role for p120-catenin in Src- and Rac1-mediated 
anchorage-independent cell growth. J Cell Biol 184, 437-
450 (2009) 
 
44.    K. Xiao, D. F. Allison, K. M. Buckley, M. D. Kottke, 
P. A. Vincent, V. Faundez and A. P. Kowalczyk: Cellular 
levels of p120 catenin function as a set point for cadherin 
expression levels in microvascular endothelial cells. J Cell 
Biol 163, 535-545 (2003) 
 
45.    M. Yanagisawa and P. Z. Anastasiadis: p120 catenin 
is essential for mesenchymal cadherin-mediated regulation 
of cell motility and invasiveness. J Cell Biol 174, 1087-
1096 (2006) 
 
46.    M. Ciesiolka, M. Delvaeye, G. Van Imschoot, V. 
Verschuere, P. McCrea, F. van Roy and K. Vleminckx: 
p120 catenin is required for morphogenetic movements 
involved in the formation of the eyes and the craniofacial 
skeleton in Xenopus. J Cell Sci 117, 4325-4339 (2004) 
 
47.    X. Fang, H. Ji, S. W. Kim, J. I. Park, T. G. Vaught, P. 
Z. Anastasiadis, M. Ciesiolka and P. D. McCrea: 
Vertebrate development requires ARVCF and p120 
catenins and their interplay with RhoA and Rac. J Cell Biol 
165, 87-98 (2004) 
 
48.    D. Gu, A. K. Sater, H. Ji, K. Cho, M. Clark, S. A. 
Stratton, M. C. Barton, Q. Lu and P. D. McCrea: Xenopus 
delta-catenin is essential in early embryogenesis and is 
functionally linked to cadherins and small GTPases. J Cell 
Sci 122, 4049-4061 (2009) 
 
49.    M. Perez-Moreno, M. A. Davis, E. Wong, H. A. 
Pasolli, A. B. Reynolds and E. Fuchs: p120-catenin 
mediates inflammatory responses in the skin. Cell 124, 
631-644 (2006) 
 
50.    M. A. Davis and A. B. Reynolds: Blocked acinar 
development, E-cadherin reduction, and intraepithelial 
neoplasia upon ablation of p120-catenin in the mouse 
salivary gland. Dev Cell 10, 21-31 (2006) 
 
51.    J. D. Bartlett, J. M. Dobeck, C. E. Tye, M. Perez-
Moreno, N. Stokes, A. B. Reynolds, E. Fuchs and Z. 
Skobe: Targeted p120-catenin ablation disrupts dental 
enamel development. PLoS One 5 (2010) 
 
52.    W. G. Smalley-Freed, A. Efimov, P. E. Burnett, S. 
P. Short, M. A. Davis, D. L. Gumucio, M. K. 
Washington, R. J. Coffey and A. B. Reynolds: p120-
catenin is essential for maintenance of barrier function 
and intestinal homeostasis in mice. J Clin Invest 120, 
1824-1835 (2010) 
 
53.    L. P. Elia, M. Yamamoto, K. Zang and L. F. 
Reichardt: p120 catenin regulates dendritic spine and 
synapse development through Rho-family GTPases and 
cadherins. Neuron 51, 43-56 (2006) 
 
54.    R. G. Oas, K. Xiao, S. Summers, K. B. Wittich, C. 
M. Chiasson, W. D. Martin, H. E. Grossniklaus, P. A. 
Vincent, A. B. Reynolds and A. P. Kowalczyk: p120-
Catenin is required for mouse vascular development. 
Circ Res 106, 941-951 (2010) 
 
55.    K. Xiao, J. Garner, K. M. Buckley, P. A. Vincent, 
C. M. Chiasson, E. Dejana, V. Faundez and A. P. 
Kowalczyk: p120-Catenin regulates clathrin-dependent 
endocytosis of VE-cadherin. Mol Biol Cell 16, 5141-
5151 (2005) 
 
56.    Y. Miyashita and M. Ozawa: Increased 
internalization of p120-uncoupled E-cadherin and a 
requirement for a dileucine motif in the cytoplasmic 
domain for endocytosis of the protein. J Biol Chem 282, 
11540-11548 (2007) 
 
57.    L. Baki, P. Marambaud, S. Efthimiopoulos, A. 
Georgakopoulos, P. Wen, W. Cui, J. Shioi, E. Koo, M. 
Ozawa, V. L. Friedrich, Jr. and N. K. Robakis: Presenilin-1 
binds cytoplasmic epithelial cadherin, inhibits 
cadherin/p120 association, and regulates stability and 
function of the cadherin/catenin adhesion complex. Proc 
Natl Acad Sci U S A 98, 2381-2386 (2001) 
 
58.    P. Marambaud, J. Shioi, G. Serban, A. 
Georgakopoulos, S. Sarner, V. Nagy, L. Baki, P. Wen, S. 
Efthimiopoulos, Z. Shao, T. Wisniewski and N. K. 
Robakis: A presenilin-1/gamma-secretase cleavage releases 
the E-cadherin intracellular domain and regulates 
disassembly of adherens junctions. EMBO J 21, 1948-1956 
(2002) 
 
59.    Y. Fujita, G. Krause, M. Scheffner, D. Zechner, H. E. 
Leddy, J. Behrens, T. Sommer and W. Birchmeier: Hakai, a 
Functions of p120ctn isoforms 
c-Cbl-like protein, ubiquitinates and induces endocytosis of 
the E-cadherin complex. Nat Cell Biol 4, 222-231 (2002) 
 
60.    S. Pece and J. S. Gutkind: E-cadherin and Hakai: 
signalling, remodeling or destruction? Nat Cell Biol 4, E72-
74 (2002) 
 
61.    Y. Miyashita and M. Ozawa: A dileucine motif in its 
cytoplasmic domain directs beta-catenin-uncoupled E-
cadherin to the lysosome. J Cell Sci 120, 4395-4406 (2007) 
 
62.    C. M. Chiasson, K. B. Wittich, P. A. Vincent, V. 
Faundez and A. P. Kowalczyk: p120-catenin inhibits VE-
cadherin internalization through a Rho-independent 
mechanism. Mol Biol Cell 20, 1970-1980 (2009) 
 
63.    W. Meng, Y. Mushika, T. Ichii and M. Takeichi: 
Anchorage of microtubule minus ends to adherens 
junctions regulates epithelial cell-cell contacts. Cell 135, 
948-959 (2008) 
 
64.    N. T. Chartier, C. I. Oddou, M. G. Laine, B. 
Ducarouge, C. A. Marie, M. R. Block and M. R. Jacquier-
Sarlin: Cyclin-dependent kinase 2/cyclin E complex is 
involved in p120 catenin (p120ctn)-dependent cell growth 
control: a new role for p120ctn in cancer. Cancer Res 67, 
9781-9790 (2007) 
 
65.    C. M. Franz and A. J. Ridley: p120 catenin associates 
with microtubules: inverse relationship between 
microtubule binding and Rho GTPase regulation. J Biol 
Chem 279, 6588-6594 (2004) 
 
66.    A. Soubry, K. Staes, E. Parthoens, S. Noppen, C. 
Stove, P. Bogaert, J. van Hengel and F. van Roy: The 
transcriptional repressor Kaiso localizes at the mitotic 
spindle and is a constituent of the pericentriolar material 
(p.1-18). PLoS ONE 5, e9203 (2010) 
 
67.    J. M. Daniel and A. B. Reynolds: The catenin 
p120(ctn) interacts with Kaiso, a novel BTB/POZ domain 
zinc finger transcription factor. Mol Cell Biol 19, 3614-
3623 (1999) 
 
68.    V. M. Braga and A. S. Yap: The challenges of 
abundance: epithelial junctions and small GTPase 
signalling. Curr Opin Cell Biol 17, 466-474 (2005) 
 
69.    K. Xiao, R. G. Oas, C. M. Chiasson and A. P. 
Kowalczyk: Role of p120-catenin in cadherin trafficking. 
Biochim Biophys Acta 1773, 8-16 (2007) 
 
70.    P. Z. Anastasiadis: p120-ctn: A nexus for contextual 
signaling via Rho GTPases. Biochim Biophys Acta 1773, 
34-46 (2007) 
 
71.    S. Ellis and H. Mellor: Regulation of endocytic traffic 
by rho family GTPases. Trends Cell Biol 10, 85-88 (2000) 
 
72.    M. Symons and N. Rusk: Control of vesicular 
trafficking by Rho GTPases. Curr Biol 13, R409-418 
(2003) 
73.    C. R. Magie, D. Pinto-Santini and S. M. Parkhurst: 
Rho1 interacts with p120ctn and alpha-catenin, and 
regulates cadherin-based adherens junction components in 
Drosophila. Development 129, 3771-3782 (2002) 
 
74.    A. B. Reynolds, J. M. Daniel, Y. Y. Mo, J. Wu and Z. 
Zhang: The novel catenin p120cas binds classical cadherins 
and induces an unusual morphological phenotype in 
NIH3T3 fibroblasts. Exp Cell Res 225, 328-337 (1996) 
 
75.    P. Z. Anastasiadis, S. Y. Moon, M. A. Thoreson, D. J. 
Mariner, H. C. Crawford, Y. Zheng and A. B. Reynolds: 
Inhibition of RhoA by p120 catenin. Nat Cell Biol 2, 637-
644 (2000) 
 
76.    N. K. Noren, B. P. Liu, K. Burridge and B. Kreft: 
p120 catenin regulates the actin cytoskeleton via Rho 
family GTPases. J Cell Biol 150, 567-580 (2000) 
 
77.    I. Grosheva, M. Shtutman, M. Elbaum and A. D. 
Bershadsky: p120 catenin affects cell motility via 
modulation of activity of Rho-family GTPases: a link 
between cell-cell contact formation and regulation of cell 
locomotion. J Cell Sci 114, 695-707 (2001) 
 
78.    S. Aho, L. Levansuo, O. Montonen, C. Kari, U. 
Rodeck and J. Uitto: Specific sequences in p120ctn 
determine subcellular distribution of its multiple isoforms 
involved in cellular adhesion of normal and malignant 
epithelial cells. J Cell Sci 115, 1391-1402 (2002) 
 
79.    G. A. Wildenberg, M. R. Dohn, R. H. Carnahan, M. 
A. Davis, N. A. Lobdell, J. Settleman and A. B. Reynolds: 
p120-catenin and p190RhoGAP regulate cell-cell adhesion 
by coordinating antagonism between Rac and Rho. Cell 
127, 1027-1039 (2006) 
 
80.    M. Yanagisawa, D. Huveldt, P. Kreinest, C. M. 
Lohse, J. C. Cheville, A. S. Parker, J. A. Copland and P. Z. 
Anastasiadis: A p120 catenin isoform switch affects Rho 
activity, induces tumor cell invasion, and predicts 
metastatic disease. J Biol Chem 283, 18344-18354 (2008) 
 
81.    D. I. Bellovin, R. C. Bates, A. Muzikansky, D. L. 
Rimm and A. M. Mercurio: Altered localization of p120 
catenin during epithelial to mesenchymal transition of 
colon carcinoma is prognostic for aggressive disease. 
Cancer Res 65, 10938-10945 (2005) 
 
82.    E. Soto, M. Yanagisawa, L. A. Marlow, J. A. 
Copland, E. A. Perez and P. Z. Anastasiadis: p120 catenin 
induces opposing effects on tumor cell growth depending 
on E-cadherin expression. J Cell Biol 183, 737-749 (2008) 
 
83.    J. Castano, G. Solanas, D. Casagolda, I. Raurell, P. 
Villagrasa, X. R. Bustelo, A. Garcia de Herreros and M. 
Dunach: Specific phosphorylation of p120-catenin 
regulatory domain differently modulates its binding to 
RhoA. Mol Cell Biol 27, 1745-1757 (2007) 
 
84.    G. R. Hoffman, N. Nassar and R. A. Cerione: 
Structure of the Rho family GTP-binding protein Cdc42 in 
Functions of p120ctn isoforms 
complex with the multifunctional regulator RhoGDI. Cell 
100, 345-356 (2000) 
 
85.    E. E. Sander, J. P. ten Klooster, S. van Delft, R. A. 
van der Kammen and J. G. Collard: Rac downregulates 
Rho activity: reciprocal balance between both GTPases 
determines cellular morphology and migratory behavior. J 
Cell Biol 147, 1009-1022 (1999) 
 
86.    A. S. Nimnual, L. J. Taylor and D. Bar-Sagi: Redox-
dependent downregulation of Rho by Rac. Nat Cell Biol 5, 
236-241 (2003) 
 
87.    C. M. Niessen and A. S. Yap: Another job for the 
talented p120-catenin. Cell 127, 875-877 (2006) 
 
88.    S. Kumper and A. J. Ridley: p120ctn and P-cadherin but 
not E-cadherin regulate cell motility and invasion of DU145 
prostate cancer cells. PLoS One 5, e11801 (2010) 
 
89.    Y. Liu, Q. Z. Dong, Y. Zhao, X. J. Dong, Y. Miao, S. D. 
Dai, Z. Q. Yang, D. Zhang, Y. Wang, Q. C. Li, C. Zhao and E. 
H. Wang: P120-catenin isoforms 1A and 3A differently affect 
invasion and proliferation of lung cancer cells. Exp Cell Res 
315, 890-898 (2009) 
 
90.    Y. Liu, Q. C. Li, Y. Miao, H. T. Xu, S. D. Dai, Q. Wei, 
Q. Z. Dong, X. J. Dong, Y. Zhao, C. Zhao and E. H. Wang: 
Ablation of p120-catenin enhances invasion and metastasis of 
human lung cancer cells. Cancer Sci 100, 441-448 (2009) 
 
91.    K. F. Kelly, C. M. Spring, A. A. Otchere and J. M. 
Daniel: NLS-dependent nuclear localization of p120ctn is 
necessary to relieve Kaiso-mediated transcriptional repression. 
J Cell Sci 117, 2675-2686 (2004) 
 
92.    P. D. McCrea, W. M. Brieher and B. M. Gumbiner: 
Induction of a secondary body axis in Xenopus by antibodies 
to beta-catenin. J Cell Biol 123, 477-484 (1993) 
 
93.    S. Y. Sokol: Wnt signaling and dorso-ventral axis 
specification in vertebrates. Curr Opin Genet Dev 9, 405-410 
(1999) 
 
94.    R. T. Moon, A. D. Kohn, G. V. DeFerrari and A. 
Kaykas: WNT and beta-catenin signalling: Diseases and 
therapies. Nat Rev Genet 5, 689-699 (2004) 
 
95.    J. Mayerle, H. Friess, M. W. Buchler, J. 
Schnekenburger, F. U. Weiss, K. P. Zimmer, W. Domschke 
and M. M. Lerch: Up-regulation, nuclear import, and tumor 
growth stimulation of the adhesion protein p120 in 
pancreatic cancer. Gastroenterology 124, 949-960 (2003) 
 
96.    A. Soubry, J. van Hengel, E. Parthoens, C. Colpaert, 
E. Van Marck, D. Waltregny, A. B. Reynolds and F. van 
Roy: Expression and nuclear location of the transcriptional 
repressor Kaiso is regulated by the tumor 
microenvironment. Cancer Res 65, 2224-2233 (2005) 
 
97.    C. R. Hosking, F. Ulloa, C. Hogan, E. C. Ferber, A. 
Figueroa, K. Gevaert, W. Birchmeier, J. Briscoe and Y. 
Fujita: The transcriptional repressor Glis2 is a novel 
binding partner for p120 catenin. Mol Biol Cell 18, 1918-
1927 (2007) 
 
98.    K. F. Kelly, A. A. Otchere, M. Graham and J. M. 
Daniel: Nuclear import of the BTB/POZ transcriptional 
regulator Kaiso. J Cell Sci 117, 6143-6152 (2004) 
 
99.    F. M. van Roy and P. D. McCrea: A role for Kaiso-
p120ctn complexes in cancer? Nat Rev Cancer 5, 956-964 
(2005) 
 
100.    S. W. Kim, X. Fang, H. Ji, A. F. Paulson, J. M. 
Daniel, M. Ciesiolka, F. van Roy and P. D. McCrea: 
Isolation and characterization of XKaiso, a transcriptional 
repressor that associates with the catenin Xp120(ctn) in 
Xenopus laevis. J Biol Chem 277, 8202-8208 (2002) 
 
101.    J. M. Daniel, C. M. Spring, H. C. Crawford, A. B. 
Reynolds and A. Baig: The p120(ctn)-binding partner 
Kaiso is a bi-modal DNA-binding protein that recognizes 
both a sequence-specific consensus and methylated CpG 
dinucleotides. Nucleic Acids Res 30, 2911-2919 (2002) 
 
102.    A. Prokhortchouk, B. Hendrich, H. Jorgensen, A. 
Ruzov, M. Wilm, G. Georgiev, A. Bird and E. 
Prokhortchouk: The p120 catenin partner Kaiso is a DNA 
methylation-dependent transcriptional repressor. Genes 
Dev 15, 1613-1618 (2001) 
 
103.    A. Ruzov, E. Savitskaya, J. A. Hackett, J. P. 
Reddington, A. Prokhortchouk, M. J. Madej, N. Chekanov, 
M. Li, D. S. Dunican, E. Prokhortchouk, S. Pennings and 
R. R. Meehan: The non-methylated DNA-binding function 
of Kaiso is not required in early Xenopus laevis 
development. Development 136, 729-738 (2009) 
 
104.    H. G. Yoon, D. W. Chan, A. B. Reynolds, J. Qin and 
J. Wong: N-CoR mediates DNA methylation-dependent 
repression through a methyl CpG binding protein Kaiso. 
Mol Cell 12, 723-734 (2003) 
 
105.    J. I. Park, S. W. Kim, J. P. Lyons, H. Ji, T. T. 
Nguyen, K. Cho, M. C. Barton, T. Deroo, K. Vleminckx, 
R. T. Moon and P. D. McCrea: Kaiso/p120-catenin and 
TCF/beta-catenin complexes coordinately regulate 
canonical Wnt gene targets. Dev Cell 8, 843-854 (2005) 
 
106.    S. W. Kim, J. I. Park, C. M. Spring, A. K. Sater, H. 
Ji, A. A. Otchere, J. M. Daniel and P. D. McCrea: Non-
canonical Wnt signals are modulated by the Kaiso 
transcriptional repressor and p120-catenin. Nat Cell Biol 6, 
1212-1220 (2004) 
 
107.    C. M. Spring, K. F. Kelly, I. O'Kelly, M. Graham, 
H. C. Crawford and J. M. Daniel: The catenin p120ctn 
inhibits Kaiso-mediated transcriptional repression of the 
beta-catenin/TCF target gene matrilysin. Exp Cell Res 305, 
253-265 (2005) 
 
108.    A. Prokhortchouk, O. Sansom, J. Selfridge, I. M. 
Caballero, S. Salozhin, D. Aithozhina, L. Cerchietti, F. G. 
Functions of p120ctn isoforms 
Meng, L. H. Augenlicht, J. M. Mariadason, B. Hendrich, A. 
Melnick, E. Prokhortchouk, A. Clarke and A. Bird: Kaiso-
deficient mice show resistance to intestinal cancer. Mol 
Cell Biol 26, 199-208 (2006) 
 
109.    A. Ruzov, D. S. Dunican, A. Prokhortchouk, S. 
Pennings, I. Stancheva, E. Prokhortchouk and R. R. 
Meehan: Kaiso is a genome-wide repressor of transcription 
that is essential for amphibian development. Development 
131, 6185-6194 (2004) 
 
110.    G. J. Filion, S. Zhenilo, S. Salozhin, D. Yamada, E. 
Prokhortchouk and P. A. Defossez: A family of human zinc 
finger proteins that bind methylated DNA and repress 
transcription. Mol Cell Biol 26, 169-181 (2006) 
 
111.    D. Casagolda, B. Del Valle-Perez, G. Valls, E. 
Lugilde, M. Vinyoles, J. Casado-Vela, G. Solanas, E. 
Batlle, A. B. Reynolds, J. I. Casal, A. G. de Herreros and 
M. Dunach: A p120-catenin-CK1epsilon complex regulates 
Wnt signaling. J Cell Sci 123, 2621-2631 (2010) 
 
112.    J. Y. Hong, J. I. Park, K. Cho, D. Gu, H. Ji, S. E. 
Artandi and P. D. McCrea: Shared molecular mechanisms 
regulate multiple catenin proteins: canonical Wnt signals 
and components modulate p120-catenin isoform-1 and 
additional p120 subfamily members. J Cell Sci 123, 4351-
4365 (2010) 
 
113.    J. I. Park, H. Ji, S. Jun, D. Gu, H. Hikasa, L. Li, S. 
Y. Sokol and P. D. McCrea: Frodo links dishevelled to the 
p120-catenin/Kaiso pathway: Distinct catenin subfamilies 
promote Wnt signals. Dev Cell 11, 683-695 (2006) 
 
114.    S. Alema and A. M. Salvatore: p120 catenin and 
phosphorylation: Mechanisms and traits of an unresolved 
issue. Biochim Biophys Acta 1773, 47-58 (2007) 
 
115.    S. Roura, S. Miravet, J. Piedra, A. Garcia de 
Herreros and M. Dunach: Regulation of E-cadherin/Catenin 
association by tyrosine phosphorylation. J Biol Chem 274, 
36734-36740 (1999) 
 
116.    J. Balsamo, T. Leung, H. Ernst, M. K. Zanin, S. 
Hoffman and J. Lilien: Regulated binding of PTP1B-like 
phosphatase to N-cadherin: control of cadherin-mediated 
adhesion by dephosphorylation of beta-catenin. J Cell Biol 
134, 801-813 (1996) 
 
117.    A. H. Huber, W. J. Nelson and W. I. Weis: Three-
dimensional structure of the Armadillo repeat region of 
beta-catenin. Cell 90, 871-882 (1997) 
 
118.    H. Aberle, H. Schwartz, H. Hoschuetzky and R. 
Kemler: Single amino acid substitutions in proteins of the 
armadillo gene family abolish their binding to alpha-
catenin. J Biol Chem 271, 1520-1526 (1996) 
 
119.    J. Piedra, S. Miravet, J. Castano, H. G. Palmer, N. 
Heisterkamp, A. Garcia de Herreros and M. Dunach: p120 
Catenin-associated Fer and Fyn tyrosine kinases regulate 
beta-catenin Tyr-142 phosphorylation and beta-catenin-
alpha-catenin Interaction. Mol Cell Biol 23, 2287-2297 
(2003) 
 
120.    P. Hu, E. J. O'Keefe and D. S. Rubenstein: Tyrosine 
phosphorylation of human keratinocyte beta-catenin and 
plakoglobin reversibly regulates their binding to E-cadherin 
and alpha-catenin. J Invest Dermatol 117, 1059-1067 
(2001) 
 
121.    M. Ozawa and T. Ohkubo: Tyrosine phosphorylation 
of p120(ctn) in v-Src transfected L cells depends on its 
association with E-cadherin and reduces adhesion activity. J 
Cell Sci 114, 503-512 (2001) 
 
122.    J. Lilien, J. Balsamo, C. Arregui and G. Xu: Turn-off, 
drop-out: functional state switching of cadherins. Dev Dyn 
224, 18-29 (2002) 
 
123.    G. Xu, A. W. Craig, P. Greer, M. Miller, P. Z. 
Anastasiadis, J. Lilien and J. Balsamo: Continuous association 
of cadherin with beta-catenin requires the non-receptor 
tyrosine-kinase Fer. J Cell Sci 117, 3207-3219 (2004) 
 
124.    D. J. Mariner, P. Anastasiadis, H. Keilhack, F. D. 
Bohmer, J. Wang and A. B. Reynolds: Identification of Src 
phosphorylation sites in the catenin p120ctn. J Biol Chem 276, 
28006-28013 (2001) 
 
125.    X. Xia, D. J. Mariner and A. B. Reynolds: Adhesion-
associated and PKC-modulated changes in serine/threonine 
phosphorylation of p120-catenin. Biochemistry 42, 9195-9204 
(2003) 
 
126.    D. J. Mariner, M. A. Davis and A. B. Reynolds: EGFR 
signaling to p120-catenin through phosphorylation at Y228. J 
Cell Sci 117, 1339-1350 (2004) 
 
127.    M. H. Vaughan, X. Xia, X. Wang, E. Chronopoulou, G. 
J. Gao, R. Campos-Gonzalez and A. B. Reynolds: Generation 
and characterization of a novel phospho-specific monoclonal 
antibody to p120-catenin serine 879. Hybridoma 26, 407-
415 (2007) 
 
128.    X. Xia, J. Brooks, R. Campos-Gonzalez and A. B. 
Reynolds: Serine and threonine phospho-specific 
antibodies to p120-catenin. Hybrid Hybridomics 23, 343-
351 (2004) 
 
129.    M. V. Brown, P. E. Burnett, M. F. Denning and A. 
B. Reynolds: PDGF receptor activation induces p120-
catenin phosphorylation at serine 879 via a PKCalpha-
dependent pathway. Exp Cell Res 315, 39-49 (2009) 
 
130.    S. Aono, S. Nakagawa, A. B. Reynolds and M. 
Takeichi: p120(ctn) acts as an inhibitory regulator of 
cadherin function in colon carcinoma cells. J Cell Biol 145, 
551-562 (1999) 
 
131.    T. Ohkubo and M. Ozawa: p120(ctn) binds to the 
membrane-proximal region of the E-cadherin cytoplasmic 
domain and is involved in modulation of adhesion activity. 
J Biol Chem 274, 21409-21415 (1999) 
Functions of p120ctn isoforms 
132.    E. Y. Wong, L. Morgan, C. Smales, P. Lang, S. E. 
Gubby and J. M. Staddon: Vascular endothelial growth 
factor stimulates dephosphorylation of the catenins p120 and 
p100 in endothelial cells. Biochem J 346 Pt1, 209-216 (2000) 
 
133.    M. J. Ratcliffe, L. L. Rubin and J. M. Staddon: 
Dephosphorylation of the cadherin-associated p100/p120 
proteins in response to activation of protein kinase C in 
epithelial cells. J Biol Chem 272, 31894-31901 (1997) 
 
134.    M. J. Ratcliffe, C. Smales and J. M. Staddon: 
Dephosphorylation of the catenins p120 and p100 in 
endothelial cells in response to inflammatory stimuli. Biochem 
J 338 Pt2, 471-478 (1999) 
 
135.    R. Rosato, J. M. Veltmaat, J. Groffen and N. 
Heisterkamp: Involvement of the tyrosine kinase fer in cell 
adhesion. Mol Cell Biol 18, 5762-5770 (1998) 
 
136.    L. Kim and T. W. Wong: The cytoplasmic tyrosine 
kinase FER is associated with the catenin-like substrate pp120 
and is activated by growth factors. Mol Cell Biol 15, 4553-
4561 (1995) 
 
137.    J. R. Downing and A. B. Reynolds: PDGF, CSF-1, and 
EGF induce tyrosine phosphorylation of p120, a pp60src 
transformation-associated substrate. Oncogene 6, 607-613 
(1991) 
 
138.    S. Shibamoto, M. Hayakawa, K. Takeuchi, T. Hori, K. 
Miyazawa, N. Kitamura, K. R. Johnson, M. J. Wheelock, N. 
Matsuyoshi, M. Takeichi and F. Ito: Association of p120, a 
tyrosine kinase substrate, with E-cadherin/catenin complexes. J 
Cell Biol 128, 949-957 (1995) 
 
139.    M. Cozzolino, B. Giovannone, A. Serafino, K. 
Knudsen, A. Levi, S. Alema and A. Salvatore: Activation 
of TrkA tyrosine kinase in embryonal carcinoma cells 
promotes cell compaction, independently of tyrosine 
phosphorylation of catenins. J Cell Sci 113, 1601-1610 
(2000) 
 
140.    S. Esser, M. G. Lampugnani, M. Corada, E. Dejana 
and W. Risau: Vascular endothelial growth factor induces 
VE-cadherin tyrosine phosphorylation in endothelial cells. 
J Cell Sci 111, 1853-1865 (1998) 
 
141.    H. Keilhack, U. Hellman, J. van Hengel, F. van Roy, 
J. Godovac-Zimmermann and F. D. Bohmer: The protein-
tyrosine phosphatase SHP-1 binds to and dephosphorylates 
p120 catenin. J Biol Chem 275, 26376-26384 (2000) 
 
142.    C. Frank, C. Burkhardt, D. Imhof, J. Ringel, O. 
Zschornig, K. Wieligmann, M. Zacharias and F. D. 
Bohmer: Effective dephosphorylation of Src substrates by 
SHP-1. J Biol Chem 279, 11375-11383 (2004) 
 
143.    L. J. Holsinger, K. Ward, B. Duffield, J. Zachwieja 
and B. Jallal: The transmembrane receptor protein tyrosine 
phosphatase DEP1 interacts with p120(ctn). Oncogene 21, 
7067-7076 (2002) 
 
144.    H. L. Palka, M. Park and N. K. Tonks: Hepatocyte 
growth factor receptor tyrosine kinase met is a substrate of 
the receptor protein-tyrosine phosphatase DEP-1. J Biol 
Chem 278, 5728-5735 (2003) 
 
145.    G. C. Zondag, A. B. Reynolds and W. H. 
Moolenaar: Receptor protein-tyrosine phosphatase 
RPTPmu binds to and dephosphorylates the catenin 
p120(ctn). J Biol Chem 275, 11264-11269 (2000) 
 
146.    H. Takeda, A. Nagafuchi, S. Yonemura, S. Tsukita, 
J. Behrens and W. Birchmeier: V-src kinase shifts the 
cadherin-based cell adhesion from the strong to the weak 
state and beta catenin is not required for the shift. J Cell 
Biol 131, 1839-1847 (1995) 
 
147.    X. Xia, R. H. Carnahan, M. H. Vaughan, G. A. 
Wildenberg and A. B. Reynolds: p120 serine and threonine 
phosphorylation is controlled by multiple ligand-receptor 
pathways but not cadherin ligation. Exp Cell Res 312, 
3336-3348 (2006) 
 
148.    E. Calautti, S. Cabodi, P. L. Stein, M. Hatzfeld, N. 
Kedersha and G. Paolo Dotto: Tyrosine phosphorylation 
and src family kinases control keratinocyte cell-cell 
adhesion. J Cell Biol 141, 1449-1465 (1998) 
 
149.    A. Skoudy, M. D. Llosas and A. Garcia de Herreros: 
Intestinal HT-29 cells with dysfunction of E-cadherin show 
increased pp60src activity and tyrosine phosphorylation of 
p120-catenin. Biochem J 317 Pt1, 279-284 (1996) 
 
150.    M. S. Kinch, G. J. Clark, C. J. Der and K. Burridge: 
Tyrosine phosphorylation regulates the adhesions of ras-
transformed breast epithelia. J Cell Biol 130, 461-471 
(1995) 
 
151.    Y. Chen, C. H. Chen, P. Y. Tung, S. H. Huang and 
S. M. Wang: An acidic extracellular pH disrupts adherens 
junctions in HepG2 cells by Src kinases-dependent 
modification of E-cadherin. J Cell Biochem 108, 851-859 
(2009) 
 
152.    P. D. McCrea and J. I. Park: Developmental 
functions of the p120-catenin subfamily. Biochim Biophys 
Acta 1773, 17-33 (2007) 
 
153.    T. Pieters, J. van Hengel and F. van Roy: Functions 
of p120ctn in development and disease. Frontiers in 
Bioscience, In press (2011*) 
 
154.    J. Pettitt, E. A. Cox, I. D. Broadbent, A. Flett and J. 
Hardin: The Caenorhabditis elegans p120 catenin 
homologue, JAC-1, modulates cadherin-catenin function 
during epidermal morphogenesis. J Cell Biol 162, 15-22 
(2003) 
 
155.    S. H. Myster, R. Cavallo, C. T. Anderson, D. T. Fox 
and M. Peifer: Drosophila p120catenin plays a supporting 
role in cell adhesion but is not an essential adherens 
junction component. J Cell Biol 160, 433-449 (2003) 
 
Functions of p120ctn isoforms 
156.    D. T. Fox, C. C. Homem, S. H. Myster, F. Wang, E. E. 
Bain and M. Peifer: Rho1 regulates Drosophila adherens 
junctions independently of p120ctn. Development 132, 4819-
4831 (2005) 
 
157.    A. F. Paulson, X. Fang, H. Ji, A. B. Reynolds and P. D. 
McCrea: Misexpression of the catenin p120(ctn)1A perturbs 
Xenopus gastrulation but does not elicit Wnt-directed axis 
specification. Dev Biol 207, 350-363 (1999) 
 
158.    K. Geis, H. Aberle, M. Kuhl, R. Kemler and D. 
Wedlich: Expression of the Armadillo family member 
p120cas1B in Xenopus embryos affects head differentiation 
but not axis formation. Dev Genes Evol 207, 471-481 (1998) 
 
159.    M. Perez-Moreno, W. Song, H. A. Pasolli, S. E. 
Williams and E. Fuchs: Loss of p120 catenin and links to 
mitotic alterations, inflammation, and skin cancer. Proc Natl 
Acad Sci U S A 105, 15399-15404 (2008) 
 
160.    D. B. Stairs, L. J. Bayne, B. Rhoades, M. E. Vega, 
T. J. Waldron, J. Kalabis, A. Klein-Szanto, J. S. Lee, J. P. 
Katz, J. A. Diehl, A. B. Reynolds, R. H. Vonderheide and A. 
K. Rustgi: Deletion of p120-catenin results in a tumor 
microenvironment with inflammation and cancer that 
establishes it as a tumor suppressor gene. Cancer Cell 19, 470-
483 (2011) 
 
161.    J. van Hengel and F. van Roy: Diverse functions of 
p120ctn in tumors. Biochim Biophys Acta 1773, 78-88 (2007) 
 
162.    M. A. Thoreson and A. B. Reynolds: Altered expression 
of the catenin p120 in human cancer: implications for tumor 
progression. Differentiation 70, 583-589 (2002) 
 
163.    A. Bonnomet, M. Polette, K. Strumane, C. Gilles, V. 
Dalstein, C. Kileztky, G. Berx, F. van Roy, P. Birembaut and 
B. Nawrocki-Raby: The E-cadherin-repressed hNanos1 gene 
induces tumor cell invasion by upregulating MT1-MMP 
expression. Oncogene 27, 3692-3699 (2008) 
 
164.    G. Berx and F. van Roy: Involvement of members of 
the cadherin superfamily in cancer. Cold Spring Harb Perspect 
Biol 1, a003129 (2009) 
 
165.    L. D. Wood, D. W. Parsons, S. Jones, J. Lin, T. 
Sjoblom, R. J. Leary, D. Shen, S. M. Boca, T. Barber, J. Ptak, 
N. Silliman, S. Szabo, Z. Dezso, V. Ustyanksky, T. 
Nikolskaya, Y. Nikolsky, R. Karchin, P. A. Wilson, J. S. 
Kaminker, Z. Zhang, R. Croshaw, J. Willis, D. Dawson, M. 
Shipitsin, J. K. Willson, S. Sukumar, K. Polyak, B. H. Park, C. 
L. Pethiyagoda, P. V. Pant, D. G. Ballinger, A. B. Sparks, J. 
Hartigan, D. R. Smith, E. Suh, N. Papadopoulos, P. 
Buckhaults, S. D. Markowitz, G. Parmigiani, K. W. Kinzler, 
V. E. Velculescu and B. Vogelstein: The genomic landscapes 
of human breast and colorectal cancers. Science 318, 1108-
1113 (2007) 
 
166.    F. Mortazavi, J. An, S. Dubinett and M. Rettig: 
p120-catenin is transcriptionally downregulated by FOXC2 
in non-small cell lung cancer cells. Mol Cancer Res 8, 762-
774 (2010) 
167.    W. E. Naugler and M. Karin: The wolf in sheep's 
clothing: the role of interleukin-6 in immunity, 
inflammation and cancer. Trends Mol Med 14, 109-119 
(2008) 
 
168.    M. L. Hermiston and J. I. Gordon: Inflammatory 
bowel disease and adenomas in mice expressing a dominant 
negative N-cadherin. Science 270, 1203-1207 (1995) 
 
169.    Y. L. Wang, A. B. Malik, Y. Sun, S. Hu, A. B. 
Reynolds, R. D. Minshall and G. Hu: Innate immune 
function of the adherens junction protein p120-catenin in 
endothelial response to endotoxin. J Immunol 186, 3180-
3187 (2011) 
 
170.    D. C. Radisky: Epithelial-mesenchymal transition. J 
Cell Sci 118, 4325-4326 (2005) 
 
171.    M. J. Wheelock, Y. Shintani, M. Maeda, Y. 
Fukumoto and K. R. Johnson: Cadherin switching. J Cell 
Sci 121, 727-735 (2008) 
 
172.    J. Behrens, L. Vakaet, R. Friis, E. Winterhager, F. 
Van Roy, M. M. Mareel and W. Birchmeier: Loss of 
epithelial differentiation and gain of invasiveness correlates 
with tyrosine phosphorylation of the E-cadherin/beta-
catenin complex in cells transformed with a temperature-
sensitive v-SRC gene. J Cell Biol 120, 757-766 (1993) 
 
173.    N. L. Tran, R. B. Nagle, A. E. Cress and R. L. 
Heimark: N-Cadherin expression in human prostate 
carcinoma cell lines. An epithelial-mesenchymal 
transformation mediating adhesion withStromal cells. Am J 
Pathol 155, 787-798 (1999) 
 
174.    J. Husmark, N. E. Heldin and M. Nilsson: N-
cadherin-mediated adhesion and aberrant catenin 
expression in anaplastic thyroid-carcinoma cell lines. Int J 
Cancer 83, 692-699 (1999) 
 
175.    B. Seidel, S. Braeg, G. Adler, D. Wedlich and A. 
Menke: E- and N-cadherin differ with respect to their 
associated p120ctn isoforms and their ability to suppress 
invasive growth in pancreatic cancer cells. Oncogene 23, 
5532-5542 (2004) 
 
176.    E. H. Wang, Y. Liu, H. T. Xu, S. D. Dai, N. Liu, C. 
Y. Xie and X. M. Yuan: Abnormal expression and 
clinicopathologic significance of p120-catenin in lung 
cancer. Histol Histopathol 21, 841-847 (2006) 
 
177.    Y. Miao, N. Liu, Y. Zhang, Y. Liu, J. H. Yu, S. D. 
Dai, H. T. Xu and E. H. Wang: p120ctn isoform 1 
expression significantly correlates with abnormal 
expression of E-cadherin and poor survival of lung cancer 
patients. Med Oncol 27, 880-886 (2010) 
 
178.    Y. Liu, H. T. Xu, S. D. Dai, Q. Wei, X. M. Yuan and 
E. H. Wang: Reduction of p120(ctn) isoforms 1 and 3 is 
significantly associated with metastatic progression of 
human lung cancer. APMIS 115, 848-856 (2007) 
 
Functions of p120ctn isoforms 
179.    R. H. Carnahan, A. Rokas, E. A. Gaucher and A. B. 
Reynolds: The molecular evolution of the p120-catenin 
subfamily and its functional associations. PLoS One 5, 
e15747 (2010) 
 
180.    M. Hatzfeld, K. J. Green and H. Sauter: Targeting of 
p0071 to desmosomes and adherens junctions is mediated 
by different protein domains. J Cell Sci 116, 1219-1233 
(2003) 
 
181.    D. J. Mariner, J. Wang and A. B. Reynolds: ARVCF 
localizes to the nucleus and adherens junction and is 
mutually exclusive with p120(ctn) in E-cadherin 
complexes. J Cell Sci 113 ( Pt 8), 1481-1490 (2000) 
 
182.    H. Sirotkin, H. O'Donnell, R. DasGupta, S. Halford, 
B. St Jore, A. Puech, S. Parimoo, B. Morrow, A. Skoultchi, 
S. M. Weissman, P. Scambler and R. Kucherlapati: 
Identification of a new human catenin gene family member 
(ARVCF) from the region deleted in velo-cardio-facial 
syndrome. Genomics 41, 75-83 (1997) 
 
183.    Q. Lu, M. Paredes, M. Medina, J. Zhou, R. Cavallo, 
M. Peifer, L. Orecchio and K. S. Kosik: delta-catenin, an 
adhesive junction-associated protein which promotes cell 
scattering. J Cell Biol 144, 519-532 (1999) 
 
184.    A. F. Paulson, E. Mooney, X. Fang, H. Ji and P. D. 
McCrea: Xarvcf, Xenopus member of the p120 catenin 
subfamily associating with cadherin juxtamembrane region. 
J Biol Chem 275, 30124-30131 (2000) 
 
185.    I. Yang, O. Chang, Q. Lu and K. Kim: Delta-catenin 
affects the localization and stability of p120-catenin by 
competitively interacting with E-cadherin. Mol Cells 29, 
233-237 (2010) 
 
186.    J. Y. Zhang, Y. Wang, D. Zhang, Z. Q. Yang, X. J. 
Dong, G. Y. Jiang, P. X. Zhang, S. D. Dai, Q. Z. Dong, Y. 
Han, S. Zhang, Q. Z. Cui and E. H. Wang: delta-Catenin 
promotes malignant phenotype of non-small cell lung 
cancer by non-competitive binding to E-cadherin with 
p120ctn in cytoplasm. J Pathol 222, 76-88 (2010) 
 
187.    O. Pertz: Spatio-temporal Rho GTPase signaling - 
where are we now? J Cell Sci 123, 1841-1850 (2010) 
 
188.    S. I. Grivennikov, F. R. Greten and M. Karin: 
Immunity, inflammation, and cancer. Cell 140, 883-899 
(2010) 
 
189.    H. Hoschuetzky, H. Aberle and R. Kemler: Beta-
catenin mediates the interaction of the cadherin-catenin 
complex with epidermal growth factor receptor. J Cell Biol 
127, 1375-1380 (1994) 
 
190.    P. Sheth, A. Seth, K. J. Atkinson, T. Gheyi, G. Kale, 
F. Giorgianni, D. M. Desiderio, C. Li, A. Naren and R. 
Rao: Acetaldehyde dissociates the PTP1B-E-cadherin-beta-
catenin complex in Caco-2 cell monolayers by a 
phosphorylation-dependent mechanism. Biochem J 402, 
291-300 (2007) 
191.    B. T. Jamal, M. Nita-Lazar, Z. Gao, B. Amin, J. 
Walker and M. A. Kukuruzinska: N-glycosylation status of 
E-cadherin controls cytoskeletal dynamics through the 
organization of distinct beta-catenin- and gamma-catenin-
containing AJs. Cell Health Cytoskelet 2009, 67-80 (2009) 
 
192.    S. M. Brady-Kalnay, T. Mourton, J. P. Nixon, G. E. 
Pietz, M. Kinch, H. Chen, R. Brackenbury, D. L. Rimm, R. 
L. Del Vecchio and N. K. Tonks: Dynamic interaction of 
PTPmu with multiple cadherins in vivo. J Cell Biol 141, 
287-296 (1998) 
 
193.    M. Hamaguchi, N. Matsuyoshi, Y. Ohnishi, B. 
Gotoh, M. Takeichi and Y. Nagai: p60v-src causes tyrosine 
phosphorylation and inactivation of the N-cadherin-catenin 
cell adhesion system. EMBO J 12, 307-314 (1993) 
 
194.    U. Cavallaro, J. Niedermeyer, M. Fuxa and G. 
Christofori: N-CAM modulates tumour-cell adhesion to 
matrix by inducing FGF-receptor signalling. Nat Cell Biol 
3, 650-657 (2001) 
 
195.    J. Balsamo, C. Arregui, T. Leung and J. Lilien: The 
nonreceptor protein tyrosine phosphatase PTP1B binds to 
the cytoplasmic domain of N-cadherin and regulates the 
cadherin-actin linkage. J Cell Biol 143, 523-532 (1998) 
 
196.    N. Lambeng, Y. Wallez, C. Rampon, F. Cand, G. 
Christe, D. Gulino-Debrac, I. Vilgrain and P. Huber: 
Vascular endothelial-cadherin tyrosine phosphorylation in 
angiogenic and quiescent adult tissues. Circ Res 96, 384-
391 (2005) 
 
197.    M. G. Lampugnani, A. Zanetti, F. Breviario, G. 
Balconi, F. Orsenigo, M. Corada, R. Spagnuolo, M. Betson, 
V. Braga and E. Dejana: VE-cadherin regulates endothelial 
actin activating Rac and increasing membrane association 
of Tiam. Mol Biol Cell 13, 1175-1189 (2002) 
 
198.    Y. Nakamura, N. Patrushev, H. Inomata, D. Mehta, 
N. Urao, H. W. Kim, M. Razvi, V. Kini, K. Mahadev, B. J. 
Goldstein, R. McKinney, T. Fukai and M. Ushio-Fukai: 
Role of protein tyrosine phosphatase 1B in vascular 
endothelial growth factor signaling and cell-cell adhesions 
in endothelial cells. Circ Res 102, 1182-1191 (2008) 
 
199.    R. Nawroth, G. Poell, A. Ranft, S. Kloep, U. 
Samulowitz, G. Fachinger, M. Golding, D. T. Shima, U. 
Deutsch and D. Vestweber: VE-PTP and VE-cadherin 
ectodomains interact to facilitate regulation of 
phosphorylation and cell contacts. EMBO J 21, 4885-4895 
(2002) 
 
200.    J. A. Ukropec, M. K. Hollinger, S. M. Salva and M. 
J. Woolkalis: SHP2 association with VE-cadherin 
complexes in human endothelial cells is regulated by 
thrombin. J Biol Chem 275, 5983-5986 (2000) 
 
201.    M. Fuchs, T. Muller, M. M. Lerch and A. Ullrich: 
Association of human protein-tyrosine phosphatase kappa 
with members of the armadillo family. J Biol Chem 271, 
16712-16719 (1996) 
Functions of p120ctn isoforms 
 
202.    B. Aicher, M. M. Lerch, T. Muller, J. Schilling and 
A. Ullrich: Cellular redistribution of protein tyrosine 
phosphatases LAR and PTPsigma by inducible proteolytic 
processing. J Cell Biol 138, 681-696 (1997) 
 
203.    R. M. Kypta, H. Su and L. F. Reichardt: Association 
between a transmembrane protein tyrosine phosphatase and 
the cadherin-catenin complex. J Cell Biol 134, 1519-1529 
(1996) 
 
204.    J. Cheng, K. Wu, M. Armanini, N. O'Rourke, D. 
Dowbenko and L. A. Lasky: A novel protein-tyrosine 
phosphatase related to the homotypically adhering kappa 
and mu receptors. J Biol Chem 272, 7264-7277 (1997) 
 
205.    H. X. Yan, Y. Q. He, H. Dong, P. Zhang, J. Z. Zeng, 
H. F. Cao, M. C. Wu and H. Y. Wang: Physical and 
functional interaction between receptor-like protein 
tyrosine phosphatase PCP-2 and beta-catenin. Biochemistry 
41, 15854-15860 (2002) 
 
206.    K. Meng, A. Rodriguez-Pena, T. Dimitrov, W. 
Chen, M. Yamin, M. Noda and T. F. Deuel: Pleiotrophin 
signals increased tyrosine phosphorylation of beta beta-
catenin through inactivation of the intrinsic catalytic 
activity of the receptor-type protein tyrosine phosphatase 
beta/zeta. Proc Natl Acad Sci U S A 97, 2603-2608 (2000) 
 
207.    R. C. Schackmann, M. van Amersfoort, J. H. 
Haarhuis, E. J. Vlug, V. A. Halim, J. M. Roodhart, J. S. 
Vermaat, E. E. Voest, P. van der Groep, P. J. van Diest, J. 
Jonkers and P. W. Derksen: Cytosolic p120-catenin 
regulates growth of metastatic lobular carcinoma through 
Rock1-mediated anoikis resistance. J Clin Invest (2011) 
 
Key words: p120ctn, catenin, Armadillo, cadherin, knock-
out, knockdown, development, trafficking, alternative 
splicing, isoforms, EMT, phosphorylation, cancer, 
RhoGTPases, RhoA, Rac1, Cdc42, Kaiso, proliferation, 
cancer, tumor, migration, invasion, inflammation, review 
 
Send correspondence to: Jolanda van Hengel, Molecular 
Cell Biology Unit, Department for Molecular Biomedical 
Research,VIB and Ghent University, Technologiepark 927, B-
9052 Ghent, Belgium, Tel: 3293313755, Fax: 3293313609, E-
mail: Jolanda.VanHengel@dmbr.VIB-Ugent.be 
 
 
 
 
 
 
 
 
 
 
 
